International Accounting Standard compliance analysis on nine pharmaceutical industries in...
Transcript of International Accounting Standard compliance analysis on nine pharmaceutical industries in...
CHAPTER 1INTRODUCTIONTHIS CHAPTER WILL COVER THE FOLLOWING THINGS THROUGH OUT ITSSPAN
Introducing reader with IFRS ,BAS , BFRS and ICAB Background of the conducting the research / study Main motive of conducting this research ; that mean research goal Drawback that might be faced by the researcher while conducting his study The valid reasons of directing such research
CHAPTER 1INTRODUCTIONTHIS CHAPTER WILL COVER THE FOLLOWING THINGS THROUGH OUT ITSSPAN
Introducing reader with IFRS ,BAS , BFRS and ICAB Background of the conducting the research / study Main motive of conducting this research ; that mean research goal Drawback that might be faced by the researcher while conducting his study The valid reasons of directing such research
CHAPTER 1INTRODUCTIONTHIS CHAPTER WILL COVER THE FOLLOWING THINGS THROUGH OUT ITSSPAN
Introducing reader with IFRS ,BAS , BFRS and ICAB Background of the conducting the research / study Main motive of conducting this research ; that mean research goal Drawback that might be faced by the researcher while conducting his study The valid reasons of directing such research
2 | P a g e
1.0 Introduction
International Financial Reporting standard is the global language of recoding, representing,
demonstrating and analyzing transaction, situations, and event affiliated with accounting. It also
provides interpretation in case of dispute raised in selection of proper standard from available
standards by reducing the number of alternative treatments. (Jon; Mouton 2000)
Day by day companies are intends to expand their business across their national boundary thus
shareholder base is created from different nation. By replacing different national accounting
standard the IFRS make it easy for the every firm operating outside their domestic market to
represent their financial position in a universal way, IAS, and also give them relief from the
complexity, difficulty, time and effort to get them accustomed to different national accounting
standard (Watts, Zimmerman, J. (1978))
IFRS helps to develop the modern era of accounting by clearly defining type of financial
statement to be prepared, financial statement objectives , qualitative characteristics of financial
statement , elements of financial statement ,rule to be exercised in recording and setting those
elements , recognition of those financial statement elements, measurement of those elements
and reporting of those financial statement element.(Zahir M.(2000))
The accounting world is wholly relies on the paths that IFRS prescribed to follow. This strong
dependency on IFRS created because IFRS conduct itself toward a broad objective “To develop
3 | P a g e
a single set of high quality, understandable, enforceable and globally accepted financial reporting
standards based upon clearly articulated principles”. To meet the objective IFRS diversify its
development activities into different internal and external standard setting bodies such as
IFRSAC, conduct activities through combined participation and systematic manner, engage with
investors, regulators, business leaders and the global accountancy profession to get support,
comments, suggestion and criticism of development activities as well as collaborate
development of different accounting standard setting bodies.
IFRS initiated for the first time to resolve accounting phenomena and give guidance in
accounting practice in the organization; operating in European Union. Later IFRS got its
popularity around the word due to its rapid development of standard and rule which leads to
record transaction in an understandable, reliable, comparable and relevant manner; consequently
created harmonized accounting across in European Union. Although there are some criticism
from the part of US and France accounting standard; more than 100 countries adopt IFRS as their
accounting standard by the end of 2008.( Tower, Hancock & Bryant;1999)
The Institute of Chartered Accountants of Bangladesh (ICAB), which is an apex body
for the development of accounting profession in Bangladesh, has been working for the
adoption and improvement of accounting standards based on the prospects of IAS. The ICAB
consistently executes programs to adopt IAS as Bangladesh Accounting Standards (BAS).
The certified auditor from ICAB also take IAS as scale of justification , analysis and giving
opinion and decision about the financial statements accuracy , financial position of the company
4 | P a g e
and giving qualified or unqualified report about the companies being audited. The Securities and
Exchange Commission (SEC) of Bangladesh requires the issuers of listed securities to prepare
financial statements in accordance with the requirements laid down in the Regulation and the
IASs as adopted by the ICAB. (Zahir M., 2000)
The stock exchange enlisted pharmaceutical industries; like other Industries; also conduct their
accounting practice in accordance with the International Financial Reporting Standards (IFRSs),
and Bangladesh Financial Reporting Standards (BFRSs). These firm comply with IFRS/ IAS in
case of revenue recognition, valuation of PPE ( property , plant and equipment) , depreciation of
PPE , recognition of asset, impairment of assets, calculation of tax , share premium and EPS ,
and preparation of prescribed financial statements
In this research paper, the main focus will be on the IAS adopted by BAS, compliance of those
IAS in accounting practice of the firm operating within pharmaceutical industry, area of
inconsistent practice of IAS , development of IAS , adoption of updated IAS by the firm of the
industry, recommendation on the whole scenario and findings of the ultimate efforts.
5 | P a g e
1.1 Background of the Study
The research paper has been conducted over 7 pharmaceutical companies’ accounting
practice in reporting and presenting financial position; entailed in their annual reports
(2011-2012) that are made to public; to realize the degree of consistency and
compliance of practicing accounting treatments with IAS rule or IFRS standards.
Since U.K based financial reporting increasing gaining its popularity around the world
due to its greater effort in affiliating national and international standard and helping
national standard setting bodies; it is prominent for Bangladesh to adopt it in all aspect
of accounting practice. As Bangladesh is a developed country it business operation is
expanding across national order and complexity in trisection is also increase at a
greater extent, it is urgent for it to comply and expertise IFRS because most of the
country related with U.K follow IFRS and IFRS provide flexibility to resolve
exceptional trisection which are not covered by existing standard by allowing to use
principle based approach (IFRS).
IFRS – Co-ordination with National standard setters is done through a process which
gives full freedom to NSS while adopting IAS/IFRS. For clear view process given
bellow –
1. Co-ordination of work plan with national standard setter (NSS)
2. IASB continue to publish ED & other documents for public comment
3. NSS publish their ED at the same time & seek comment on significant
divergence b/w two
4. NSS follow their own full due process
6 | P a g e
So our study is about to compliance of BAS with IAS and Adoption of IAS in
parasitical industries
1.2. Objective of the Study
To find out the IAS compliance with BAS practicing within these companies Also
interpret the area where BAS is somehow differs from related IAS rules
Sorting the BAS and IAS from the whole population of BAS and IAS principle or rule
( which are exercising within the industry ) and creating a relative comparison among
them
A little bit analysis on company performance to justify whether full application IAS is
more successful then customized IAS for the nation or industry
Point out the auditors opinion and the guideline they follow in case of auditing in the
industry
Interpreting draw backs of IAS or BAS , Epitomize the finding and giving
recommendation
7 | P a g e
1.3. Limitation of the Study
The study faced various problems which have been tried to overcome but there are some certain
limitations. The major limitations are:
Limitation of the study
The study is not based on the population, it’s based on sample. So the entire
scenario cannot be found here.
This study is for educational purpose. No professional purpose is included in
this report.
Data collection is done from secondary sources as well beside publication IASB and
ICAB. So, the reliability of this data is related with publishers, writer or analysts made
sources of secondary data.
I have few practical experiences in analyzing the Annual Reports. So, there
may be some lack of professionalism in this report
Provability of skipping prominent data for the study mistakenly
Shortage of time , assistance and resources
There is only one source for finding the annual reports in Bangladesh. Only
SEC (securities & Exchange Commission) reference room is the only source
of these annual reports
Some judgments are made on assumption, finding or secondary data. So I can’t provide
100% assurance on all analysis , judgments and discussion that I made throughout the
report
8 | P a g e
1.4. Rationality of the Study
Every work or effort is directed to get something effective in use or get something which
contains utility to the person performing it or other. Our attempt to conduct the study is not
exceptional in that sense. We conduct our study to get idea about ---
Scenario of accounting practice in Bangladesh by analyzing an industry- pharmaceutical
industry- as a sample
How advance the accounting practice of Bangladesh on the side of compliance of IAS ;
which has growing importance in now a days
Procuring knowledge about national standard of accounting practice ; developed on the
light of IAS ; developed by Bangladesh national standard setting bodies
Whether any major change has been made in case of applying IAS or BAS or new
adoption of IAS has been made in recent years in pharmaceutical industries
At all ; help in developing mindset and gaining know-how about how different
instrument , rule and principle is applied in real business world practice ; which
consequently provide us a practical view about different standards and thus put a strong
scar on the mind plot
9 | P a g e
CHAPTER 2THEORITICAL FRAMEWORKTHIS CHAPTER WILL COVER THE FOLLOWING THINGS
Covering approaches of accounting Presenting major difference between IFRS and GAAP A little bit focus on regulatory system of IFRS Discuss about IFRS standard setting procedure Depicting conceptual framework of IFRS Importance or benefits of IFRS adoption
9 | P a g e
CHAPTER 2THEORITICAL FRAMEWORKTHIS CHAPTER WILL COVER THE FOLLOWING THINGS
Covering approaches of accounting Presenting major difference between IFRS and GAAP A little bit focus on regulatory system of IFRS Discuss about IFRS standard setting procedure Depicting conceptual framework of IFRS Importance or benefits of IFRS adoption
9 | P a g e
CHAPTER 2THEORITICAL FRAMEWORKTHIS CHAPTER WILL COVER THE FOLLOWING THINGS
Covering approaches of accounting Presenting major difference between IFRS and GAAP A little bit focus on regulatory system of IFRS Discuss about IFRS standard setting procedure Depicting conceptual framework of IFRS Importance or benefits of IFRS adoption
10 | P a g e
2.0 Two Major Approaches of Accounting
Companies operating across globe adopt one of two main approach of accounting named- IFRS(
international Financial reporting standard ) and GAAP( generally Accepted Principles);
providing guideline in preparing, reporting and representing all sorts of accounting information,
trisections and event and even resolving dispute. (Street, Gray & Bryant; 1999)
The basic difference between IFRS and GAAP are –
1. IFRS is principle based and GAAP is principle based
2. IFRS is developed by standard setting body named IASB( international Standard
Setting bodies ) whether GAAP is developed by FASB (International Accounting
Standard Board )
3. IFRS is U.K based approach and GAAP is U.S based approach
There are other similarities and dissimilarities exist between these major domains of standards
given in following exhibits-
Topic GAAP IFRS IFRS for SMEs (small and mediumsize entities )Fundamental basis Generally , specificguideline and rules Generally moreprinciple andjudgmental basedand few specificguideline and rulesGenerally moreprinciple andjudgmental basedand few specificguideline and rulesLIFO inventorycosting Allowed Not allowed Not allowed
Inventoryvaluation Lower of cost ormarket Lower of cost ornet realized value Lower of cost ornet realized valueGoodwill carryingvalue Goodwill is notamortized ; 2 stepimpairment test Not amortized ;one stepimpairment test Amortized forperiod up to 10years ; one stepimpairment test
11 | P a g e
Impairment andwrite downs No reversal Can be reversed (except goodwill) Can be reversed (except goodwillLeasing Guideline andspecific tests Similar guidance ;no specific test Similar guidance ;no specific testReserves Record whenprobable Record when “more like than not” Record when “more like than not”Consolidation Consider variableinterest first thenvoting interest Non variableinterest entityequivalent butsimilar guideline ;evaluate all controlelements andconsolidatedcontrolled entities
Non variableinterest entityequivalent butsimilar guideline ;evaluate all controlelements andconsolidatedcontrolled entitiesR&D costs Generally bothconsidered asexpense Research isexpensed anddevelopment iscapitalizedBoth are expensed
Borrowing cost forself – constructedassets Generallycapitalized andamortized Generallycapitalized andamortized ExpensedHedge accounting Rigorous andspecific guidanceto apply hedgeaccounting
Rigorous andspecific guidanceto apply hedgeaccountingSimplified ; onlycertain hedgetypes allowed
12 | P a g e
2.1. Regulatory System and Regulatory Bodies of Accounting on the
Perspective of IFRS Standards
The regulatory system of accounting in IFRS is comprised with three major regulatory bodies
named-
IASC (international Accounting standard committee) or IFRS foundation:
this body; comprising with 22 trustees; is responsible for all governance issues , inquiring of
whether other standard setting bodies are properly founded or not , developing universal
standard, application of those standards in generating relevant information for investors and
creditors , promotion of those standard and setting a bridge among national and internal
accounting standards
The IASB (International Accounting Standard Setting Bodies):
This body is founded with 14 members and responsible for issuing new-new standard overtime
with the change of situation, condition and circumstances. The developed standard of this body
is previously known as IAS ( international accounting standard) but now a day the name is
replaced by IFRS( international financial reporting standard). Mission, vision, objective and
responsibilities are identical and consistent with IASC/ IFRS foundation
The IFRIC /IFRS foundation:
This body issue rapid guidance on accounting matters whenever a conflicting situation arise in
case of applying standard ( IFRS ); usually happens in case of dealing with alternative accounting
treatment accountant will face dilemma in making make choice about which standard is need
to be selected. For example: IFRIC 1, IFRIC 2 etc (interpretation set given by IFRIC)
13 | P a g e
It is important to know about IFRIC and in gist IFRIC is –
The SAC (standards Advisory Council) or IFRS Advisory council:
SAC provide a forum of professional from different professional fields, business and location to
assist in developing standards and creating new standards.
There are some important know how about SAC are –
Provide guidance on application and interpretation of IFRSDeals with newly identified FR issues not addressed in IFRSIssues where unsatisfactory or conflicting interpretation have developed or likely to develop
SAC features SAC featuresGive advice to board and trustees of IASB Meetings discussion and finding is open topublicComprises of 50 members Advise IASB on prioritization of its work andon Implication of proposed standardsConsistently Consulted by IASB on all projectsand aspects of its functioningMeets at least 3 times a year with IASBtrustees for discussing important issues
14 | P a g e
The relationship among these bodies can be articulated as follow—
Advice
Appointed by
Appointed by appoint report to
Report to overview
Govern fraud
Interpretation
Creates
Trustee Appointment Advisory Group Trustee advise IASC Foundation to appoint, overview and govern fraud in IASB ,IFRIC
and SAC
IASC Govern , appoint and overview SAC and IFRIC
IASB report to IASC and create IFRS standards
SAC report to IASC and help IASB in case of developing new standards
IFRC provide interpretation to IFRS standard ; issued by IASB
TrusteeAppointment
AdvisoryGroup
IASC foundation
IASB
SAC
IFRIC
IFRS standards
15 | P a g e
2.2 Formation Process of IAS/ IFRS with the Combined Effort ofSAC, IASB and IASC
The creation of new standard or amendment made to the existing standard is done througha straight forward way.
The procedure of development of new IFRS is as follow-
step 1
• Forming a forum of professionbal from different business , professional areas andloacality
• Assigning the professional group to advise IASB in case of developing standard s (IFRS/IAS)
step 2
• Identify the subject to be adressed by intended standard ; need to be developed• Deployed professionals analyze the suject and gather idea about how to represent the
subject in a relevent and appropriate way in the aspect of accounting treat ment .Inform IASB about the best ideas about adressing the subject which coonsequentlyenable IASB to develop strandards
step 3• Make a exposer darft of the intended standard ; which actually a draft version of the
future standards
Step 4• publish the exposer draft to the public to encurage public comment, perception , idea
and sugession on the intended standards
Step 5• Based on the consideration of the relevent comments ; received in draft ; IASB
decide whther to finalize the indented standards or not or is there any nacaessityto make any amendment on the drafted standards
step 6• At any stage IASB has full right to issue dicussion paper to encurage public
,professioan and members comments
Step 7• The publication of IFRS , IFRIC interpration ,exposer dardft and final standrd
will became in practice and public only when 8 out of 14 members of IASBagreed together
15 | P a g e
2.2 Formation Process of IAS/ IFRS with the Combined Effort ofSAC, IASB and IASC
The creation of new standard or amendment made to the existing standard is done througha straight forward way.
The procedure of development of new IFRS is as follow-
• Forming a forum of professionbal from different business , professional areas andloacality
• Assigning the professional group to advise IASB in case of developing standard s (IFRS/IAS)
• Identify the subject to be adressed by intended standard ; need to be developed• Deployed professionals analyze the suject and gather idea about how to represent the
subject in a relevent and appropriate way in the aspect of accounting treat ment .Inform IASB about the best ideas about adressing the subject which coonsequentlyenable IASB to develop strandards
• Make a exposer darft of the intended standard ; which actually a draft version of thefuture standards
• publish the exposer draft to the public to encurage public comment, perception , ideaand sugession on the intended standards
• Based on the consideration of the relevent comments ; received in draft ; IASBdecide whther to finalize the indented standards or not or is there any nacaessityto make any amendment on the drafted standards
• At any stage IASB has full right to issue dicussion paper to encurage public,professioan and members comments
• The publication of IFRS , IFRIC interpration ,exposer dardft and final standrdwill became in practice and public only when 8 out of 14 members of IASBagreed together
15 | P a g e
2.2 Formation Process of IAS/ IFRS with the Combined Effort ofSAC, IASB and IASC
The creation of new standard or amendment made to the existing standard is done througha straight forward way.
The procedure of development of new IFRS is as follow-
• Forming a forum of professionbal from different business , professional areas andloacality
• Assigning the professional group to advise IASB in case of developing standard s (IFRS/IAS)
• Identify the subject to be adressed by intended standard ; need to be developed• Deployed professionals analyze the suject and gather idea about how to represent the
subject in a relevent and appropriate way in the aspect of accounting treat ment .Inform IASB about the best ideas about adressing the subject which coonsequentlyenable IASB to develop strandards
• Make a exposer darft of the intended standard ; which actually a draft version of thefuture standards
• publish the exposer draft to the public to encurage public comment, perception , ideaand sugession on the intended standards
• Based on the consideration of the relevent comments ; received in draft ; IASBdecide whther to finalize the indented standards or not or is there any nacaessityto make any amendment on the drafted standards
• At any stage IASB has full right to issue dicussion paper to encurage public,professioan and members comments
• The publication of IFRS , IFRIC interpration ,exposer dardft and final standrdwill became in practice and public only when 8 out of 14 members of IASBagreed together
16 | P a g e
2.3 Benefits of Adoption and Compliance of IFRS/IAS
There are numerous benefits of applying IAS / IFRS in accounting practice. The major benefitsare noted bellow to realize the opportunity cost of using IAS rather than using national standard.
Benefits of IAS /IFRS application
Provide Better financial information for shareholders
Better financial information for regulators
Enhanced internal and external comparability
Improved transparency of results
Increased ability to secure cross-border listing; Better management of global operations; anddecreased cost of capital.
17 | P a g e
2.4. Conceptual Framework of IFRS / IAS
The IASB Framework was approved by the IASC Board in April 1989 for publication in July
1989, and adopted by the IASB in April 2001.
Conceptual framework define the nature and purpose of accounting as well as deals with
theoretical and conceptual issues related with financial reporting; thus forming a coherent and
consistent foundation for developing accounting standard .more specifically conceptual
framework is a coherent system of interconnected objectives and prominent principle which
recommend the nature, function, limit and convention of financial accounting and financial
statements.
Conceptual framework is important because it ensure the consistent development of accounting
standard or GAAP in accordance with established principles. Fire fighting situation is carefully
handled by conceptual framework thus reduce conflicts between different accounting standards
or accounting standards and legislation. If conceptual framework is not applied consistently,
more important issues relating with development of a certain standard will be overlooked willy-
nilly. Conceptual framework covers exceptional transactions; which are not the subject of an
accounting standard; by using its increased flexibility. Conceptual framework of accounting is
two dimensional – (1) FASB based and (2) IASB based.
FASB based conceptual frame deals with ---
a. The objective of financial statements;
b. The qualitative characteristics that determine the usefulness of information in
financial statements;
c. The definition, recognition and measurement of the elements from which
financial statements are constructed; and
d. Concepts of capital and capital maintenance.
18 | P a g e
Objective of financial statements:
The objective of financial statements is to provide information about the financial
position, performance and changes in financial position of an entity that is useful to a
wide range of users in making economic decisions. Financial statements prepared for this
purpose meet the common needs of most users. However, financial statements do not
provide all the information that users may need to make economic decisions since they
largely portray the financial effects of past events and do not necessarily provide non-
financial information.
In order to meet their objectives, financial statements are prepared on the accrual basis of
accounting.
The financial statements are normally prepared on the assumption that an entity is a going
concern and will continue in operation for the foreseeable future.
Qualitative characteristics:
Qualitative characteristics are the attributes that make the information provided in
financial statements useful to users. The four principal qualitative characteristics are
understandability, relevance, reliability and comparability. In practice a balancing, or
trade-off, between qualitative characteristics is often necessary.
Elements related with financial statements:
The elements directly related to the measurement of “financial position” are assets,
liabilities and equity. These are defined as follows:
i. An asset is a resource controlled by the entity as a result of past events and
from which future economic benefits are expected to flow to the entity.
19 | P a g e
ii. A liability is a present obligation of the entity arising from past events, the
settlement of which is expected to result in an outflow from the entity of
resources embodying economic benefits.
iii. Equity is the residual interest in the assets of the entity after deducting all
its liabilities.
The elements of “income and expenses “are defined as follows:
i. Income is increases in economic benefits during the accounting period in
the form of inflows or enhancements of assets or decreases of liabilities
that result in increases in equity, other than those relating to contributions
from equity participants.
ii. Expenses are decreases in economic benefits during the accounting period
in the form of outflows or depletions of assets or incurrence of liabilities
that result in decreases in equity, other than those relating to distributions
to equity participants.
An item that meets the definition of an element should be recognized if:
i. It is probable that any future economic benefit associated with the item
will flow to or from the entity; and
ii. The item has a cost or value that can be measured with reliability.
Measurement is the process of determining the monetary amounts at which the elements
of the financial statements are to be recognized and carried in the balance sheet and
income statement. This involves the selection of the particular basis of measurement.
20 | P a g e
The concept of capital maintenance:
I. The concept of capital maintenance is concerned with how an entity defines the
capital that it needs to maintain.
II. It provides the connection between the concepts of capital and the concepts of
profit because it provides the reference by which profit is measured only
inflows of assets in excess of amounts needed to maintain capital may be
regarded as profit and therefore as a return on capital.
III. Therefore, profit is the surplus amount that remains after expenses (including
capital maintenance adjustments, where appropriate) have been deducted from
income. If expenses exceed income the residual amount is a loss.
Figure: Conceptual framework of IFR
objectives
elements ; qualitativecharactaristics
recognition criteris ;financial statement vs.financial reporting ;
measurements
reporting earning , reporting findflow & lequidity ; financial
statement and other means offinancial reporting
20 | P a g e
The concept of capital maintenance:
I. The concept of capital maintenance is concerned with how an entity defines the
capital that it needs to maintain.
II. It provides the connection between the concepts of capital and the concepts of
profit because it provides the reference by which profit is measured only
inflows of assets in excess of amounts needed to maintain capital may be
regarded as profit and therefore as a return on capital.
III. Therefore, profit is the surplus amount that remains after expenses (including
capital maintenance adjustments, where appropriate) have been deducted from
income. If expenses exceed income the residual amount is a loss.
Figure: Conceptual framework of IFR
objectives
• Fundamentalselements ; qualitative
charactaristics
• operational
recognition criteris ;financial statement vs.financial reporting ;
measurements
• Display
reporting earning , reporting findflow & lequidity ; financial
statement and other means offinancial reporting
20 | P a g e
The concept of capital maintenance:
I. The concept of capital maintenance is concerned with how an entity defines the
capital that it needs to maintain.
II. It provides the connection between the concepts of capital and the concepts of
profit because it provides the reference by which profit is measured only
inflows of assets in excess of amounts needed to maintain capital may be
regarded as profit and therefore as a return on capital.
III. Therefore, profit is the surplus amount that remains after expenses (including
capital maintenance adjustments, where appropriate) have been deducted from
income. If expenses exceed income the residual amount is a loss.
Figure: Conceptual framework of IFR
• Fundamentals
• operational
• Display
21 | P a g e
CHAPTER 3LITERATURE REVIEWTHIS CHAPTER WILL ENTAIL THE THINGS GIVEN BELLOW:
A brief history of IFRS emergence and its acceptance over the world as internationalaccounting standard
Why adoption of IFRS is required in the era of globalization? Positive impact of IFRS adoption through BAS in Bangladesh IFRS and IAS first time adoption track in Bangladesh A theoretical analysis of all IAS based on IAS adoption practice in Bangladesh
pharmaceutical firm
21 | P a g e
CHAPTER 3LITERATURE REVIEWTHIS CHAPTER WILL ENTAIL THE THINGS GIVEN BELLOW:
A brief history of IFRS emergence and its acceptance over the world as internationalaccounting standard
Why adoption of IFRS is required in the era of globalization? Positive impact of IFRS adoption through BAS in Bangladesh IFRS and IAS first time adoption track in Bangladesh A theoretical analysis of all IAS based on IAS adoption practice in Bangladesh
pharmaceutical firm
21 | P a g e
CHAPTER 3LITERATURE REVIEWTHIS CHAPTER WILL ENTAIL THE THINGS GIVEN BELLOW:
A brief history of IFRS emergence and its acceptance over the world as internationalaccounting standard
Why adoption of IFRS is required in the era of globalization? Positive impact of IFRS adoption through BAS in Bangladesh IFRS and IAS first time adoption track in Bangladesh A theoretical analysis of all IAS based on IAS adoption practice in Bangladesh
pharmaceutical firm
22 | P a g e
3.0. History of IFRS and BFRS and movement of both standardsevolving overtime:
Now a day IASB issues all IFRS and exert inconsistent effort on development of IFRS to
make it more flexible, understandable, easily applicable and universally acceptable. But
before the inception of IASB the IASC initiate the first effort in standard development
field for the best accountancy. IASC is a body established in 1973 through an
agreement made by professional accountancy bodies from Australia, Canada, France,
Germany, Japan, Mexico, the Netherlands, the United Kingdom and Ireland, and the
United States of America.
Up to 2000, the IASC’s rules were described as “International Accounting Standards”
(IAS).
In 1997 after nearly 25 years of glorious attainments; IASC realized that to continue a
smooth development process in IAS, it must find out a way to make bridge between
national accounting standards and practices and high-quality global accounting standards.
In late 1997 IASC formed a Strategy Working Party that published a discussion paper in
December 1998 and final recommendations in November 1999. The IASC Board
approved the proposal by December 1999, and the IASC member bodies did the same in
May 2000. The new standards-setting body was named as International Accounting
23 | P a g e
Standards Board (IASB) and it has been performing the rule-making function from April
2001.
Major helping bodies operating as a non-separable part of IASB reporting and
development structure contain- IASB, IASC Foundation, International Financial
Reporting Interpretations Committee (IFRIC), previously Standing Interpretations
Committee, SIC under IASC), Standards Advisory Council (SAC) and Working Groups.
IASB has good finance for development, good freedom in making decision and good
forum of professional to lead its operation. So this body is one of the successfully
operating bodies formed by IASC in 2001.
The IASB describes its rules under the new tag “International Financial Reporting
Standards (IFRS), though it honors the prior rules (IAS) issued by the old standard-setter
(IASC).
In order to achieve objective like – setting an accounting system which enhance
comparability , consistency , reduces accounting conflict ( rising due to increasing
complexity for extensive globalization) and ensure uniqueness -- the accounting
profession developed the solutions like: the American solution GAAP or the European
solution (British solution to be read) IAS/IFRS. On the backdrop of getting a single set of
international accounting standards (since October 2002, the IASB and FASB have been
24 | P a g e
working thoroughly toward convergence of IFRS and U.S. GAAP), IFRS is rapidly
gaining acceptance as over 100 countries; have recently moved to IFRS reporting or
decided to require the use of these standards in the near future and even the U.S.
Between 2005 and 2006, the number of foreign private issuers filing with the SEC using
IFRS jumped from a handful to 110, and the SEC expects the number to continue to
increase (IASB report; 2005).In February 2006, SEC Chairman Christopher Cox
reaffirmed the SEC’s commitment to achieving one set of high quality, globally accepted
accounting standards and opened the possibility that U.S. financial statements could be
prepared using IFRS or U.S. GAAP.
Within few year after the formation of new standard setting body ( IASB), the SEC
announced its support of a memorandum of understanding named “the Norwalk
Agreement”; done between the Financial Accounting Standards Board (FASB) and the
International Accounting Standards Board( IASB).
In between 2005 and 2006, the number of foreign private issuers filing with the SEC
using IFRS jumped from a few number to 110. Thus SEC predicts the increasing number
of adoption of IFRS in future. .In February 2006, SEC Chairman Christopher Cox unveils
the possibility that U.S. financial statements could be prepared using IFRS or U.S.
GAAP. In 2007, the SEC allows foreign private issuer (PIs) to prepare financial
25 | P a g e
statements in accordance with IFRS as issued by the IASB without any reconciliation to
GAAP. SEC timeline (Baitter; 2007) is given bellow for further clarification---
Figure: 1.1
EU requires publicly held companies to prepare financial statement, report and discloser
based on the IFRS /IAS by January 1; 2005. Countries with prominent capital market like
-Australia, Hong Kong, Singapore and South Africa decided to adopt and has already
adopt accounting system equivalent to IFRS/IAS. Even SEC allows any enlisted firm to
switch from GAAP to IFRS/IAS. Organization of Securities Commissions (IOSCO), the
25 | P a g e
statements in accordance with IFRS as issued by the IASB without any reconciliation to
GAAP. SEC timeline (Baitter; 2007) is given bellow for further clarification---
Figure: 1.1
EU requires publicly held companies to prepare financial statement, report and discloser
based on the IFRS /IAS by January 1; 2005. Countries with prominent capital market like
-Australia, Hong Kong, Singapore and South Africa decided to adopt and has already
adopt accounting system equivalent to IFRS/IAS. Even SEC allows any enlisted firm to
switch from GAAP to IFRS/IAS. Organization of Securities Commissions (IOSCO), the
25 | P a g e
statements in accordance with IFRS as issued by the IASB without any reconciliation to
GAAP. SEC timeline (Baitter; 2007) is given bellow for further clarification---
Figure: 1.1
EU requires publicly held companies to prepare financial statement, report and discloser
based on the IFRS /IAS by January 1; 2005. Countries with prominent capital market like
-Australia, Hong Kong, Singapore and South Africa decided to adopt and has already
adopt accounting system equivalent to IFRS/IAS. Even SEC allows any enlisted firm to
switch from GAAP to IFRS/IAS. Organization of Securities Commissions (IOSCO), the
26 | P a g e
international organization of national securities regulators, has suggested its members to
permit foreign issuers to use IFRS for cross-border securities offerings and listings. IASB
has been indefatigable in promoting IFRS at a political level.
The FASB and the IASB say they will revise the Norwalk Agreement to create a one set
of accounting standards from which all significant capital markets would be able to
operate by 2013.
IASs have become an essential part of the legal framework of Bangladesh from 1997 by
insertion of section 12(2) into the Securities and Exchange Rules 1987. The ICAB has
been adopted 29 out of 34 IASs as Bangladesh Accounting Standards (BAS); which is
around 85% compliance with IFRS or IAS.
27 | P a g e
3.1. What does IFRS adoption mean and what are the terminologies relatedwith adoption?. “Nobes and Zeff (2010)”, give a definition of IFRS adoption to mean the full-scale
voluntary use by a company of IFRS as issued by the IASB before such use become
compulsory or mandatory in its jurisdiction. By this definition, two forms of IFRS
adoption can be observed.
I. First, a voluntary application of the IASBs standards without any alteration of the
standards and
II. Second a mandatory adoption of IFRSs where legal provisions require
jurisdictions to apply IFRS as issued by the IASB to the latter.
Beyond these two types of IFRS adoption, other countries often use another form of
adoption. This form of adoption reminds us of the due process through which
International Accounting Standards are produced. The due process in setting International
Accounting Standards is that, constituents identify areas in financial reporting that needs
to be improved. Following this, the technical staff at the IASB develops a discussion
paper that issued to the public for comments over a limited period. They then design the
proposed standard into an Exposure Draft, which is showcased to the public for further
comments and public hearings before a substantive IFRSs can be pronounced. Notable
among countries that have adopted this due process are Australia, Canada and New
Zealand. In this approach, adopting countries will first translate IFRS into their local
standards following the due process of the IASB. Whether by content or by process, IFRS
adoption refers to the complete replacement of IFRSs with any other standard a country
might have.
Let us for a moment look at the terminology, which the IASB uses when referring the
IFRS adoption. The board has on several occasions referred to different forms of IFRS
applications yet in fact meaning IFRS ‘’adoption’’. In their recent annual report, they
provide the state of IFRS adoption around the world as seen in the list below-
28 | P a g e
Table: IFRS Application in Some developed countries. Source: IASB annual report 2011 pg (3)
This list suggests that the IASB has in many instances contradicted themselves when they speak
of IFRS adoption. Take China for example; can we say that they have adopted IFRSs? The
answer is “No” because the Chinese have their own national accounting standards. It is true that
Chinese National Accounting Standards are now closer to IFRSs than ever before. However, in
essence, China cannot claim to have adopted IFRS.
IFRS Adoption List as Provided by the IASBYear Country2012 G20: two thirds of G20 members now require the use of IFRSs
2011 Russia: announces intention to adopt IFRSs from 2012 IFRS for SMEs: nearly 80
jurisdictions have adopted the IFRS for SMEs, or announced plans to do so
2008 Malaysia and Mexico: announce intention to adopt IFRSs
2006 China: adopts accounting standards substantially in line with IFRSs, with goal of
full convergence
2005 Nearly 7000 Companies adopt IFRS in the European Union including South Africa
and Simultaneously switch over from national GAAP to IFRS for listed companies
2007 Bangladesh started to reform their national accounting standard in accordance with
IAS published by IFRS
29 | P a g e
3.2. BAS Adoption of IFRS / IAS over the time being in Bangladesh:
Since Bangladesh is facing a rapid escalation in foreign trisection, increasing number of
multinational firm in domestic market and effect of globalization; adoption as well as
compliance with IAS is became prominent. Because most of the developed country now a day
exercising IAS
Here I want to represent a summary of total number of IAS rule that has been adopted by ICAB
and it equivalent BFRSs from the very beginning of the adoption to adoption that had been made
recently.
If someone carefully observe the adoption and compliance tack then they will surely realized that
most of the adoption is made in 2007and in near future our BAS will be more enriched and
appropriate with the full adoption or compliance with IAS. Besides that there is a treat of
abolishment of BAS by IAS.
International Accounting Standard Compliance and Adoption
IAS No. Title Status of adoption and
compliance by ICAB
Effective date as BAS
1 Presentation of
Financial Statements
Adopted 1st January 2007
2 Inventories Adopted 1st January 2007
7 Cash Flow Statements Adopted 1st January 1999
8 Accounting Policies,
Changes in Accounting
Estimates and Errors
Adopted 1st January 2007
30 | P a g e
10 Events after the Balance
Sheet Date
Adopted 1st January 2007
11 Construction Contracts Adopted 1st January 1999
12 Income Taxes Adopted 1st January 1999
16 Property, Plant and
Equipment
Adopted 1st January 2007
17 Leases Adopted 1st January 2007
18 Revenue Adopted 1st January 2007
19 Employee Benefits Adopted 1st January 2004
20 Accounting for
Government Grants and
Disclosure
of Government
Assistance
Adopted 1st January 1999
21 The Effects of Changes
in Foreign Exchange
Rates
Adopted 1st January 2007
23 Borrowing Costs Adopted 1st January 2010
24 Related Party
Disclosures
Adopted 1st January 2007
26 Accounting and
Reporting by
Retirement Benefit
Adopted 1st January 2007
31 | P a g e
Plans
27 Consolidated and
Separate Financial
Statements
Adopted 1st January 2010
28 Investments in
Associates
Adopted 1st January 2007
29 Financial Reporting in
Hyperinflationary
Economies
Not adopted –
inapplicable in
Bangladeshi context
----------------------
31 Interests in Joint
Ventures
Adopted 1st January 2007
32 Financial Instruments:
Presentation
Adopted 1st January 2010
33 Earnings per Share Adopted 1st January 2007
34 Interim Financial
Reporting
Adopted 1st January 1999
36 Impairment of Assets Adopted 1st January 2005
37 Provisions, Contingent
Liabilities and
Contingent
Assets
Adopted 1st January 2007
38 Intangible Assets Adopted 1st January 2005
32 | P a g e
39 Financial Instruments:
Recognition and
Measurement
Adopted 1st January 2010
40 Investment Property Adopted 1st January 2007
41 Agriculture Adopted 1st January 2007
Table: (Source) ICAB website, ICAB annual report 2011
There are some other IFRS adoption made in between 2007 – 2013; but most of these adoption
and compliance is made in 2013—
IFRS Adoption and Compliance
IFRS No. IFRS titles Status of adoption and
compliance by ICAB
Effective Date as BFRS
1 First time Adoption of
International Financial
Reporting
Standards
Adopted 1st January 2009
33 | P a g e
2 Share Based Payment Adopted 1st January 2007
3 Business Combinations Adopted 1st January 2010
4 Insurance Contracts Adopted 1st January 2010
5 Non Current Assets held
for Sale and
Discontinued
Operations
Adopted
1st January 2007
6 Exploration for and
Evaluation of Mineral
Resources
Adopted 1st January 2007
7 Financial Instruments:
Disclosures
Adopted 1st January 2013
8 Operating Segments Adopted 1st January 2013
9 Financial Instruments Not adopted---not
applicable in
Bangladeshi context
-------
10 Consolidated Financial
Statements
Adopted 1st January 2013
11 Joint Arrangements Adopted 1st January 2013
12 Disclosure of Interests
in Other Entities
Adopted 1st January 2013
13 Fair Value Adopted 1st January 2013
34 | P a g e
Measurement
Table: (Source) ICAB website, ICAB annual report 2011
3.3. Positive Impact on the National Accounting Practice of Bangladesh Due to
Adoption of IFRS
In a developing country like Bangladesh, we can figure out the following prospects that may be
materialized by the adoption of IFRS:
1. The adoption may have some strong impact on the corporate sector. Agency problem
between management and shareholders can be substantially reduced through execution of
IFRS as increased transparency causes managers to act more in the interests of the
shareholders (see Watts, 1977; Watts and Zimmerman, 1986). The increased
transparency promised by IFRS also could cause a similar increase in the efficiency of
contracting between firms and lenders. The increased transparency and loss recognition
timeliness promised by IFRS could increase the efficiency of contracting in debt markets,
with potential gains to equity investors in terms of reduced cost of debt capital
.
2. The weakness of small investors is a long time established problem and undoubtedly it is
a big obstacle for the stock market development in Bangladesh. Small investors are less
likely than investment professionals to be able to anticipate financial statement
information from other sources. IFRS adoption could reduce the cost of investors of
processing financial information. Improving financial reporting quality allows the small
investors to compete better with professionals, and hence reduces the risk they are trading
with a better-informed professional (known as “adverse selection”).
35 | P a g e
3. Another improvement of adopting IFRS to reduce information irregularity in the
corporate sector can arise due to its emphasis on fair value accounting (FVA). Most
economists argue that fair value incorporates more information into the financial
statements than historical costs. Though other conditions in Bangladesh are not favorable
for implementing FVA (like achieving observable market prices or independently
observable, accurate estimates of liquid market prices that cannot be materially
influenced by managers due to less perfect market liquidity), still FVA can make
financial statements more informative, with potential advantages to investors, and if
enforceable more useful for purposes of contracting with lenders, managers and other
parties (see Ball, Robin and Sadka (2006). IFRSs are instilled into FVA. Particularly as
listed (Ball 2005):
a) IFRS 2 requires share-based payments to be accounted at fair value;
b) IFRS 3 provides for minority interest to be recorded at fair value;
c) IAS 16 provides a fair value option for property, plant and equipment;
d) IAS 36 requires asset impairments (and impairment reversals) to fair value;
e) IAS 38 requires intangible asset impairments to fair value and some others;
f) IAS 39 requires fair value for financial instruments other than loans and
receivables that are not held for trading, securities held to maturity; and
qualifying hedges (which must be near-perfect to qualify); and
g) IAS 40 provides a fair value option for investment property.
36 | P a g e
4. Apart from these, adoption of IFRS in Bangladesh can reduce accounting diversity thus
will encourage the foreigners for cross border investment which in turn may improve the
liquidity of the capital markets and enlarge firm’s investor base to improve risk-sharing
and lowers cost of capital (e.g. Merton, 1987).
5. Prevailing local GAAP is not enough to ensure proper disclosure quality and there are
ambiguities among numerous rules, guidelines and notifications that are often self-
contradictory and perplexing to one another. Mandatory adoption of IFRS will reduce
such vagueness and create more binding on the firms to perform their disclosure
responsibility (e.g., Ding et al, 2007; Baee Tan and Welker, 2008 evidence that IFRS are
more comprehensive than most local GAAP). Since the early 1980s, various bilateral and
multilateral agencies have been playing an active role in the diffusion of Western
accounting standards to the developing world (see Rahaman and Lawrance, 2001;
Neuetal., 2002). Bangladesh, as a country hugely dependent on foreign aid and also a
participant of globalization trend, has been facing the urgency of different global
community for adopting IASs/IFRSs to ensure accountability and transparency in
financial reporting.
Accounting profession is seeking to adopt all applicable IASs (see Institute of Cost and
Management Accountants of Bangladesh, 1999, p. 12) but such decision is continually driven by
institutional legitimization rather than careful appreciation of the differing contextual variables in
Bangladesh (see, Susela, 1999; Points and Cunningham, 1998). In fact, after a long period
without any involvement or interference with the practice of accounting, the government of
37 | P a g e
Bangladesh, in response to the immense pressure by the international lending/donor agencies to
standardize financial reporting, has started lobbying the accounting profession to adopt all
applicable IASs/IFRSs for use in Bangladesh (ICMAB, 1999).
3.4. Problem Faced by Standard Setting Bodies of BAS During AdoptionProcess of IAS:
The general perception is: after the standards (BAS) are reviewed and adopted; that most of these
standards are carbon copies with the same numbers as the original IASs. (Miretal, 2005, p. 826)
Another problem lies on ambiguity of role and responsibility of the SEC and the ICAB. Once the
adoption process is over the SEC then has the responsibility, as delegated by the Government of
Bangladesh, to monitor compliance with these standards by listed companies. According to the
Sec 12 (2) of the Securities and Exchange Rules 1987, ‘the financial statements of an issuer of a
listed security shall be prepared in accordance with the requirements laid down in the Schedule
and the International Accounting Standards/IFRSs as adopted by the Institute of Chartered
Accountants of Bangladesh’. That is, all the responsibilities of IAS adoption process lie with the
ICAB. The SEC does not participate in the process though it is the top regulatory body in
Bangladesh for enforcement of IASs/IFRSs in the listed companies. Here it may be noted that the
US SEC has the authority to set accounting standards for companies, but always has delegated
the responsibility to the accounting profession, a strong and independent standards setting body
like FASB. Most importantly, the US SEC delegated only the responsibility, not the authority, to
set standards and if it does not agree with a particular standard issued by the private sector, it can
force a change in the standard (See Spiceland et al, 2004, p. 9). It is clear that, in Bangladesh,
38 | P a g e
SEC lacks expertise to formulate standards which led them to delegate the responsibility to the
ICAB.
From a diagnostic review carried out in Bangladesh on accounting and auditing in January –
March 2003, the World Bank’s Report on the Observance of Standards and Codes (ROSC)
Bangladesh states that, the accounting and auditing practices in Bangladesh suffer from
institutional weaknesses in regulation, compliance, and enforcement of standards and rules. In
many cases, the preparation of financial statements and conduct of audits are not consistent with
IASs and international auditing practices
The ROSC (Report on the Observance of Standards and Codes (World Bank)) revealed the
necessity of enacting of “a new Financial Reporting Act and the repeal of the provisions on
accounting, auditing, and financial reporting in Companies Act 1994, Bank Companies Act
1991, Insurance Act 1938, and other related regulations.” This recommendation is appreciable
because such initiative may substantially eliminate all conflicting issues among the prevailing
regulations and pronouncements and undoubtedly, it will be easy to update accounting, auditing,
and financial reporting requirements from time to time by simply amending the single act for
financial reporting. The ROSC advocated that the proposed Financial Reporting Act should
focus on making legal arrangements to “fully adopt IAS/IFRS/ and ISA without modification
and ensure mandatory observance of these standards” (ROSC, 2003, p.11)
39 | P a g e
3.5 Selected 9 Company’s Compliance with IAS on the Year 2013(ATheoretical Justification and Comparison):
Selected sample companies compliance with different IAS adopted BAS in case of preparing,
analyzing, presenting and reporting financial statements and practicing accounting policies and
procedures are justified and analyzed bellow under the title of different IAS adopted BAS. For
this purpose we will use 2013 scenario of all companies.
3.5.0 “IAS -1 Presentation of Financial Statement” Compliance
IAS -1 requirements Sample companies compliance
Preparation of Financial Statement such as –
1. a statement of financial position as at the
end of the period;
2. a statement of comprehensive income for
the period;
3. a statement of changes in equity for the
period;
4. a statement of cash flows for the period
5. Notes to the financial statement
Fully complied with this requirement
1. On year 2013 the companies prepare
statement of financial position
2. On the year 2013 it creates Statement of
comprehensive income
3. On the year 2013 the company create
statement of cash flow
4. Statement of change in capital is created
on the year 2013
5. Notes to the financial statement are also
disclosed fully by representing all element
included in above statements to clarify
them to general stockholders
40 | P a g e
Financial statement should represent the reflection
of the principle going concern.
Prepared financial statements on a going concern
basis which are reflected in its long-term asset,
liabilities. There are no doubt about the
continuance of going concern because the
companies have facing a upward growth
consistently ; thus no discloser of uncertainty
about going-concern is not necessary in the year
2013
Additional discloser when necessary There was no major occurrence happened to give
additional discloser on the year 2013
Decision: So we can say that all sample companies are complying with IAS-1
3.5.1. “IAS -2 Inventories” Compliance
IAS -2 requirements Sample companies compliance
Inventories shall be measured at the lower of cost and
net realizable value
Yes; the companies comply with this requirement
and describe about it in notes with title inventory
on year 2013.
The cost of inventories on year 2013 comprises of
expenditure incurred in the normal course of
business in bringing the inventories to their
present location and condition. Net realizable
value is based on estimated selling price less any
41 | P a g e
further costs expected to be incurred to make the
sale
The cost of inventories shall be assigned by ether
using the first-in, first-out (FIFO) or using
weighted average cost formula.
Cost is determined on weighted average cost
basis in year 2013 in all selected companies.
Decision : The companies conform with IAS-2 fully
3.5.2. “IAS-7 Statement of Cash Flow” Compliance
IAS -7 requirements Sample companies compliance
The statement of cash flows shall report cash
flows during the period classified by operating,
investing and financing activities.
The company maintains this requirement. the
cash flow statement of year 2013( common
structure to all sample companies is given
bellow ( figure 6.0.3 yellow shaded areas)
Follow ether direct method or indirect method The companies used direct cost method because
it report major classes of gross cash receipts and
gross cash payments in case of calculation of CF
from operating activities.
42 | P a g e
(7out of 9 sample companies name ) Pharmaceuticals Limited
Statement of Cash Flow
For the year ended 31 December 2013
Particulars Taka
Cash Flows from Operating Activities :
Receipts from Customers and Others
Payments to Suppliers and Employees
Cash Generated from Operations
Interest Paid
Interest Received
Income Tax Paid
Net Cash Generated from Operating Activities
Cash Flows from Investing Activities :
Acquisition of Property, Plant and Equipment
Intangible Assets
Disposal of Property, Plant and Equipment
Short Term Investment
Net Cash Used in Investing Activities
Cash Flows from Financing Activities :
Net Decrease in Long Term Borrowings
Net Increase / (Decrease) in Short Term Borrowings
Dividend Paid
Net Cash Generated from Financing Activities
43 | P a g e
Increase in Cash and Cash Equivalents
Cash and Cash Equivalents at Beginning of Year
Cash and Cash Equivalents at End of Year
Figure: (Cash flow statement structure of all selected companies)
Decision: The Companies complies with IAS-7 by preparing cash flow statement in
accordance with direct method.
3.5.3. IAS 12 Income Taxes- Compliance
IAS -12 requirements Sample companies compliance
Income tax expense comprises of current and
deferred tax.
1. Current tax liabilities/assets for the current
and prior periods shall be calculated at the
amount expected to be paid to the taxation
authorities; using the tax rates/tax laws that
have been enacted or substantively enacted
by the end of the reporting period
2. Deferred tax assets and liabilities shall be
measured at the tax rates that are expected
to apply to the period when the asset is
The company comply with the tax related rules –
IAS 12 in 2013 by-
1. Current tax expense has been recognized on
the basis of the Finance Act 2012 and
Income Tax Ordinance 1984.” The Finance
act and income tax ordinance 1984 are just
intended to determine tax rate but basis of
calculating income tax return is based on
IAS -12.
2. The company has recognized deferred tax
using balance sheet method in compliance
with the provisions of IAS 12: Income
44 | P a g e
realized or the liability is settled, based on
tax rates (and tax laws) that have been
enacted or substantively enacted by the end
of the reporting period
Taxes.
The company’s policy of recognition of
deferred tax assets/ liabilities is based on
temporary differences between the
carrying amount (Book value) of assets and
liabilities for financial reporting purpose
and its tax base
Decision: the company fulfills IAS-12 with full compliance with every knock and
corner of the rules in case of recognizing and calculating income tax.
45 | P a g e
3.5.4“IAS 16 - Property, Plant and Equipment” Compliance
IAS-16 requirements Sample companies compliance
Property, plant and equipment will be treated astangible items that will fulfill these requirementsgiven bellow :1. are held for use in the production or supplyof goods or services, for rental to others, orfor administrative purposes; and2. are expected to be used during more thanone period
They treat these common asset as tangible which
fulfill the 2 conditions for tangible asset given on
adjacent box—
Building and Other Construction
Plant and Machinery
Furniture & Fixtures
Transport & Vehicle
Office Equipment
Measurement after recognition-
1. Cost model: After recognition as an asset,
an item of property, plant and equipment
shall be carried at its cost less any
accumulated depreciation and any
accumulated impairment losses.
2. The revaluation model: After recognition
as an asset; whose fair value can be
measured reliably shall be carried at a
1. PP&E has been stated at cost or revalued
amount less accumulated depreciation in
compliance with the requirements of IAS
16
2. Not maintained the second requirement in
case of recognizing any of tangible assets
46 | P a g e
revalued amount; being its fair value at the
date of the revaluation less any subsequent
accumulated depreciation and subsequent
accumulated impairment losses
Depreciation is the systematic allocation of the
depreciable amount of an asset over its useful life.
Depreciable amount is the cost of an asset, or other
amount substituted for cost, less its residual value
Depreciation is presented to amortize the cost of
the assets after commissioning, over the period of
their expected useful lives, in compliance with the
provisions of IAS 16
Depreciation is provided at the rates on reducing
balance basis ; given bellow:
Building and Other Construction (2% to
10%)
Plant and Machinery (5% to 15%)
Furniture & Fixtures 10%
Transport & Vehicle 20%
Office Equipment 10% -15%
47 | P a g e
Decision: all of the 10 companies completely maintain the provision of IAS 16
3.5.5. The IAS Rule that the Companies Skips in Between IAS1 – IAS17
IAS Rules Sample companies compliance
IAS 8 “Accounting Policies, Changes in
Accounting Estimates and Errors”
No change in accounting principle is made in
year 2013 so this provision is overlooked by
the companies
IAS 10 Events after the Reporting Period This part is mainly for auditors to follow; so
the companies skip this provision
Decision : all of the 10 companies doesn’t comply with IAS 7 and 10 willy-nilly
3.5.6. IAS 17 Leases compliance as leaser
IAS-17 requirements Sample companies compliance
Provision for two types of lease from the
perspective of leasors-
1. Operating lease:
Lessor shall present assets subject to
operating leases in their statements of
1. No operating lease is continuing within this
company; so the company doesn’t
obligated to follow the part of this
48 | P a g e
financial position according to the nature
of the asset (consider whether asset is fixed
or current).
The depreciation policy for depreciable
leased assets shall be consistent with the
lessor’s normal depreciation policy for
similar assets, and depreciation shall be
calculated in accordance with IAS 16 and
IAS 38.
Lease income from operating leases shall
be recognized in income on a straight-line
basis over the lease term
2. Finance lease: Lessors shall recognize
assets held under a finance lease in their
statements of financial position and present
them as a receivable at an amount equal to
the net investment in the lease
Costs incurred by manufacturer or dealer
lessors in connection with negotiating and
arranging a lease shall be recognized as an
expense when the selling profit is
provision
2. In compliance with the IAS 17: Leases,
cost of assets acquired under finance lease
along with related obligation has been
accounted for as assets and liabilities
respectively of the companies, and the
interest element has been charged as
expenses
49 | P a g e
recognized
Decision: Most of the companies maintain this IAS provision partially by only
exercising it in accounting treatments on financial lease. Some of the company
totally skip this provision due to absence of any leasing activities/ transactions
3.5.7. IAS 18 “revenue” Compliance Justification
IAS-18 requirements Sample companies compliance
This Standard shall be applied in accounting for
revenue arising from the following transactions
and events-
1. the sale of goods: Revenue from the sale
of goods shall be recognized when all the
following conditions have been fulfilled-
the entity has transferred to the
buyer
the amount of revenue can be
measured reliably;
the economic benefits associated
with the transaction will flow to
Respective compliance of the sample companies
in different requirements of this IAS provisions
1. Revenue is recognized upon invoicing the
customers for goods sold and delivered.
Sales are accounted for net of value added
tax, trade discount and allowances.
In case of cash delivery, revenue is
recognized when delivery is made and
cash is received by the Companies
50 | P a g e
the entity
costs incurred in respect of the
transaction can be measured
reliably
2. The rendering of services
3. The use by others of entity assets yielding
interest, royalties and dividend
2. Revenue from services given is
documented in income statement in
proportion to the stage of completion of
the transaction at the reporting date.
3. When the Group acts as an agent, the
revenue is recognized in the net amount of
commission earned by the Group.
Dividend income is recognized when right
to receive payment of such dividend is
recognized
Common costs and facilities are allocated
to entities based on common cost sharing
agreement and pursued constantly.
51 | P a g e
Cash flows from operating activities have
been presented under direct method
Decision: all the companies under consideration consistently maintain this IAS-18
since the year 2002.
Findings:
Sales of good is recorded as fair value
Service revenue is recognized as per as the proportion of whole service completed
Dividend and commission is recognized when those are earned
Cash flow from operating activities are recorded at direct method rather than
indirect method
52 | P a g e
3.5.8. IAS 19-“Employee Benefits” Compliance
IAS 19 requirement Sample companies compliance
Short-term employee benefits requirements:
Short-term employee benefits are
employee benefits that are need to be
settled within twelve months after the
end of the period in which the employees
render the related service.
Company should recognize the
undiscounted amount of short-term
employee benefits expected to be paid in
exchange for that service either :
(a) as a liability (accrued expense),
after subtracting any amount
already paid
If the amount paid exceeds the
undiscounted amount of the
benefits, an entity shall recognize
that excess amount as prepaid
expense
Or
Short-term employee benefits include
salaries, bonuses, leave encashment, etc.
; which are exhausted within 12 month
in the year 2013
Obligations for such benefits are
measured on an undiscounted basis and
are expensed as the related service is
provided in the year 2013
53 | P a g e
(b) as an expense, unless another
Standard( such as IAS2 –
inventory and IAS16-PP&E)
requires or permits the insertion
of the benefits in the cost of an
asset
Post-employment benefits requirement :
Post-employment benefits are employee
benefits (other than termination benefits)
which are payable after the completion
of employment.
Post-employment benefits: defined
contribution plans:
(a) Under defined contribution plans:
the entity’s legal or constructive
obligation is limited to the amount
that it agrees to contribute to the fund
Post employment benefits are provident
fund, gratuity, life insurance policy etc
are maintained by the companies for
their employees
(a) Defined benefit plan runs within the
companies
The companies have a registered
provident fund scheme (Defined
Contribution Plan) for employees of the
company eligible to be members of the
54 | P a g e
(b) Actuarial risk (that benefits will be
less than expected) and investment
risk (that assets invested will be
insufficient to meet expected
benefits) fall on the employee.
fund in agreement with the rules of the
provident fund constituted under an
irrevocable trust. All permanent
employees of those companies contribute
10% of their basic salary to the provident
fund and the company also makes equal
contribution.
Employees of these companies are
entitled to gratuity (Defined Benefit
Plans) benefit after completion of
minimum five years of service in the
company.
(b) no valuation was done to quantify
actuarial liabilities as per the IAS 19
Decisions: the sample companies follow IAS 19 partially in case some defined benefit
and terminal benefits plan but fully follow in case of short term benefit plans
55 | P a g e
3.5.9. IAS 20 Accounting for Government Grants and Disclosure of
Government Assistance Compliance:
These companies are non-government entity and rarely got assistance from the part of
government. For this reason the companies doesn’t comply with IAS-20. Other reason for which
the companies fight shy this IAS provisions are given bellow –
1. No government grants ;assistance by government in the form of transfers of resources
to an entity ; are made in form of asset / income in the year 2013 among these
companies
2. No government assistance ; action taken by government designed to provide an
economic benefit specific to an entity ; are made in the year 2013 among these
companies
3.5.10. IAS 21The Affects of Changes in Foreign Exchange Rates
IAS-21 requirements Sample companies compliance
Reporting foreign currency transactions in the
functional currency requirements –
At the end of each reporting period:
1. foreign currency monetary items shall
be translated using the closing rate;
All the companies deals with functional
currencies in the following manner----
1. Foreign currency transactions are
accounted for at exchange rate
existing on the date of transaction.
Monetary assets and liabilities
56 | P a g e
2. non-monetary items that are measured
in terms of historical cost in a foreign
currency shall be translated using the
exchange rate at the date of the
transaction; and
3. non-monetary items that are measured
at fair value in a foreign currency shall
be translated using the exchange rates
at the date when the fair value was
determined
denominated in foreign currencies at
reporting date are translated at rates
;existing on balance sheet date
2. Remain unmet by most of the
companies due to absence of non-
monetary transaction in foreign
currency
3. Remain unmet by most of the
companies due to absence of non-
monetary transaction in foreign
currency
Decision: All of the elected companies follow IAS-21 requirements in case of dealing
with foreign currency except non- monetary trisection made on foreign currency.
57 | P a g e
3.5.11. IAS 23 Borrowing Costs- compliance
IAS 23requirements Sample companies compliances
Recognition:
1. An entity shall capitalize borrowing costs that
are directly attributable to the acquisition,
construction or production of a qualifying
asset as part of the cost of that asset.
2. An entity shall recognize other borrowing
costs as an expense in the period of incurred
3. Entity shall begin capitalizing borrowing
costs as part of the cost of a qualifying asset
on the commencement date.
The commencement date for capitalization is
the date when the entity first meets all of the
following conditions:
(a) it incurs expenditures for the asset;
1. In the year 2013 companies capitalizes
borrowing cost; incurred in establishing new
projects
2. Borrowing Cost Borrowing costs are
recognized as expenses in the period in which
they are incurred unless capitalization of such
is allowed under IAS 23: Borrowing Costs.
3. Charges the cost (interest on loan) to revenue
account as financial expenses after
commencement of the commercial operation
of new projects.
58 | P a g e
(b) it incurs borrowing costs; and
(c) it undertakes activities that are necessary to
prepare the asset for its intended use or sale
Decision: companies whose are intended to take loan for establishing new project
obligate to this provision by capitalizing cost related to borrowing until the project is on
the operation. Companies; taking loan for other purpose rather than acquisition,
construction or production of a qualifying asset are also comply with this provision by
recording borrowing cost as financial expense
3.5.12. IAS 24 Related Party Disclosures- compliance
IAS 24 requirements Sample companies compliance
Disclose management personnel compensation in
total and for each of the following categories:
1. short-term employee benefits;
2. post-employment benefits;
3. other long-term benefits;
4. termination benefits; and
5. share-based payment
In 2013 all the companies disclose fully about –
1. salaries, bonuses, leave encashment
2. insurance premiums, healthcare premiums
,deferred-compensation arrangements,
pension and gratuity
3. long service leave
4. Nil
5. Nil
Discloser about related party trisections Sufficient discloser has been made in the year 2013
59 | P a g e
about transactions made among parent; entities with
joint control or significant; subsidiaries; associates;
joint ventures in which the entity is a venture; and
other related parties. Decisions: All the companies comply with IAS 24 by giving sufficient discloser for all
the trisection relating with related parties.
3.5.13. IAS 26 “Accounting and Reporting by Retirement Benefit Plans”-
Compliance
IAS 26 is somehow correlated with IAS 16 and helps each other in case of reporting, recognizing
and setting structure of employee post- employment benefits. The elected pharmaceutical
companies fully company with both IAS provision in case of determining post-employment
benefits such as pension fund, gratuity payment, life insurance scheme benefits and differed
salary payments. The aspect based on which we are sure about the companies’ compliance with
IAS 26 are –
1. The companies recognize retirement benefit at fair value which is one of the
requirement of IAS 26
2. In case of marketable securities ; the companies carried them at their fair market value
3. financial statements of a retirement benefit plan for ether defined and undefined
contains all of the following information in the year 2013 ; which are recommended by
IAS 26—
A statement of changes in net assets available for benefits
60 | P a g e
A summary of significant accounting policies
An interpretation of the plan and the effect of any changes in the plan during
the period
3.5.14. IAS 27 “Consolidated and Separate Financial Statements”-Compliance
Verification
The companies whose are operating in a parent-subsidiary relationship are intend to consolidate
their financial statement as like as they are operating as a single company but with a different
entity. In the sample size; there some companies who are operate in several industries such as
Beximco and create consolidated –
Statement of financial position
Statement of comprehensive income
Statement of change in cash flows
Notes to the Financial statements and by this those companies reflect the some
requirements of IAS 27 such as –
1. reflection of relationship of the parent –subsidiary ;
2. consolidation of financial statements must present financial information about the
group as that of a single economic entity
The companies in their financial statement position represent about minority shareholder’s
interest under non-controlling interest in the year 2013 in case of when the companies doesn’t
fully take over their subsidiaries. Thus fulfill other requirements of IAS 27 –
61 | P a g e
1. Recording non-controlling interest
2. Showing change in ownership interest
Decision: so we can that the companies are fully docile in case of complying IAS 27.
3.5.15. IAS 28 Investments in Associates –Compliance
This IAS provision is applied only to treat investments that the 10 companies made in associated
parties and joint venture and the companies has a significant investment in associates through
purchasing about 20-50% of common outstanding share of associates.
In such types of investment there is no necessity to prepare consolidated financial statements.
Equity method should be adopted by the entity and initial investment should be recorded at cost
and this original cost need to be adjusted in later period for the contrition to gain/ loss earned by
associates.
The companies in 2013 has incurred different investments that they made in associated
companies dealing with other product line or divisions and they record and treat those incurred
investment on the light of IAS 28. The reason for which we are pretty sure about their
compliance are-
1. Associates are determined based on percentage of ownership scale of 20-50%
2. All investment made to Associates and joint ventures are accounted for using the equity
method
62 | P a g e
3. Investment made to associates are recorded at the total cost incurred while making share
purchase of associates and investments are adjusted each period for pro-portion of gain/
loss from associates in the manner given bellow –
Demo:
A company purchase 22% of share of B Company and incurs a cost of 20000. B company
record a net income and dividend at that year of about 2000 take and 500 taka
successively. A company will record those in accordance with equity method because A
has significant influence over B.
Then A company will record acquisition of common stock as bellow –
D
e
c
i
s
i
o
n
s
: So we can say that all of the companies follow IAS 28 in case of accounting
investment in associates.
Particulars Taka Taka
Investment made in B’s stock ----Dr
Cash -------------------------Cr
(To record share purchase)
20000
20000
Investment made in B’s Stock -----Dr
Income from B -----------------Cr
(To record share of net income from B)
440 440
Cash -----------------------------------Dr
Investment in B’s stock ------Cr
(To record share of dividend)
110 110
63 | P a g e
3.5.16. IAS 29 Financial Reporting in Hyperinflationary Economies –
Compliance
This is IAS standard is incompatible in Bangladesh perspective because it belong out of the
boundary of hyperinflation because it face a reducing inflation rates rate overtime and has good
pricing index.
The reasons why Bangladesh industries are not obligate to follow IAS 29 is the mismatch
between Bangladesh economic scenario and IAS prescribed hyperinflationary economic
characteristics.
Characteristics Hyperinflationary economies described by IAS 29 are as follow-
1. The general population prefers to keep its wealth in non-monetary assets or in a relatively
stable foreign currency. Amounts of local currency held are immediately invested to
maintain purchasing power;
2. The general population regards monetary amounts not in terms of the local currency but
in terms of a relatively stable foreign currency. Prices may be quoted in that currency;
3. Sales and purchases on credit take place at prices that compensate for the expected loss of
purchasing power during the credit period, even if the period is short;
4. Interest rates, wages and prices are linked to a price index; and
5. The cumulative inflation rate over three years is approaching, or exceeds, 100%.
Characteristics of Bangladesh economic scenario-
64 | P a g e
1. General people have a tendency of expending money rather than saving money. Only
11.23% of total population has intention to save money in term different non-monetary
forms
2. Most of the product price fabricated inside Bangladesh has price tag written in taka.
3. Sale or purchase is made mostly on cash and if made in credit then the price and payment
condition will be fixed by the both parties or other regulatory bodies.
4. Interest is determined by market demand or govt. Wage is determined by working
performance and price is determined based on quality and service.
5. Cumulative inflating rate is 44.5% for successive three year (2011, 2012, and 2013)
which is less than 100%.
Decision: since Bangladesh is a developing country and doesn’t belong to
hyperinflationary economy; so the selected companies doesn’t adopt this IAS provision
3.5.17. IAS 31 Interests in Joint Ventures- Compliance
Since any of the selected companies has no percentage of ownership interest in othercompanies in between 20-50%; there is no existence of joint-venture as well as no interestrelated to investment made in joint venture. So the companies are not compelled to followIAS 31 provision.The reason; proving a strong evidence against not complying with IAS 31; are givenbellow—
65 | P a g e
The reason for which the companies doesn’t follow IAS 31 in year 2013
The companies has no joint venture assets, liabilities, income and expenses whichare need are the main concern of the IAS 31 There are no jointly controlled operational are run by those companies. No jointly controlled asset or shared facility are notified in the discloser of financialstatement in the year 2013 All the establishment of a corporation, partnership or other entity has no jointventure interest All the financial statement are prepared in a consolidated manner ( used in parent-subsidiary relationship) rather than using proportionate consolidation method orequity method ( to record investments; change in equity , income , expense made togain significant control over the investee) Since no joint venture relation exist among those companies; the transactionbetween venture and joint venture are absurd here. Even any significant transfer ,sale and purchase of assets has not been notified in2013 annual report in between companies with strategic and informal relationship Decision: the industry completely bypasses the IAS 31 provision due to absence of joint-
venture relation within the alignment of the industry.
66 | P a g e
3.5.18. IAS 32 Financial Instruments: Presentation-Compliance
IAS 32 requirements Sample companies compliance
Financial instrument must include assets such as
1. cash/ cash equivalent ,
2. Term deposit
3. Trade receivable
4. equity instrument of another entity ( as
investment )
5. contractual right to receive cash or another
financial asset from another entity or to
exchange financial assets or financial
liabilities with another entity under conditions
that are potentially favorable to the entity
In 2013 ; asset as a financial instrument contains
the following items
1. cash and cash equivalents
2. term deposit
3. trade receivables,
4. investments in shares
5. No such types of item are disclosed in
financial statement
Financial instrument must include the following
liabilities-
1. contractual obligation
2. a contract that will or may be settled in the
entity’s own equity instruments
In the year 2013 the companies report the items ;
meeting with following two categories; as
follow-
1. trade payable
2. interest bearing borrowing
67 | P a g e
Financial instrument must include the following
equity elements such as –
1. Share capital
2. All types of capital reserve
In the year 2013 the companies report share
capital, revaluation reserve, general reserve,
retained earnings etc under equity section of
balance sheet.
Decision: The Company fully discloses all financial instruments according to the
guidance given by IAS 31 rule.
68 | P a g e
CHAPTER 4METHODOLOGYTHIS CHAPTER WILL COVER:
The method through which we will collect , analyze , shot , and arrange data forgetting a good research outcome
We also give a gist of what the topic on which we will conduct our research in laterperiod
The sample size of the interested subject to conduct research will also bedetermined in this chapter
The name of the pharmaceutical firms ; that we chose as our sample; are mentionat the end of this chapter
68 | P a g e
CHAPTER 4METHODOLOGYTHIS CHAPTER WILL COVER:
The method through which we will collect , analyze , shot , and arrange data forgetting a good research outcome
We also give a gist of what the topic on which we will conduct our research in laterperiod
The sample size of the interested subject to conduct research will also bedetermined in this chapter
The name of the pharmaceutical firms ; that we chose as our sample; are mentionat the end of this chapter
68 | P a g e
CHAPTER 4METHODOLOGYTHIS CHAPTER WILL COVER:
The method through which we will collect , analyze , shot , and arrange data forgetting a good research outcome
We also give a gist of what the topic on which we will conduct our research in laterperiod
The sample size of the interested subject to conduct research will also bedetermined in this chapter
The name of the pharmaceutical firms ; that we chose as our sample; are mentionat the end of this chapter
69 | P a g e
4.0. Methodology:
Reports are prepared using various data and in processing the data various methods are used. The
basic method used in analyzing financial reporting disclosures is to scrutinize the Annual
Reports of the non-life insurance companies using checklists.
4.1 Data Collection and Analysis Procedures:
In Bangladesh many pharmaceutical companies are non-listed with the SEC and therefore their
shares are not traded in the DSE and CSE. Since they are non-listed companies, it is not expected
that those companies will prepared their Annual Reports on a regular basis, as well as they will
prepare it at all. For this reason, the listed companies have been used as the basis to work on.
In total there are 46 pharmaceutical firms of listed and non-listed category. Among these 46 are
listed companies. I chose 10 leading firm among those 46 listed firms as the sample of this study
and collect annual report of those selected companies respective annual reports ; published at the
end of the year 2012-2013. All of the Annual Reports are collected from the published Annual
Reports found in the pharmaceutical company’s websites. Some information has been collected
from the Journal of published by the Bangladesh Pharmaceutical Society (BPS).
I have prepared a detailed checklist and collected the required data from the Annual Reports of
the companies. The checklist has been filled up with the required data from those reports. After
collecting different field of data, I have calculated the qualitative and quantitative data based on
predetermined analysis tools used to analyze whether those companies are complying with IAS
by honoring BAS. Most of the relevant are presented in different graphical form since graphs
reflect the data more continently and vividly. Then I compared the companies with its own
reporting disclosures, other companies as well and IAS/ BAS standard to trace the area of
70 | P a g e
compliance and noncompliance of IAS in the entire industry. The number of disclosure made by
the pharmaceutical companies in the industry is compared with the other companies in the same
industry. Ultimate goal of all the effort is to conduct the inter industry analysis to justify
compliance of IAS /BAS in industry accounting practice.
4.2 Subject Matter of the Study
The subject matter of the study is about to justify whether firms operating in Bangladesh
pharmaceutical industry (belongs to life science category of comical industry; contributing 35 %
to this broader industry) comply with IAS in their accounting practice or not; if doesn’t comply
then provide explanation against non-compliance with IAS.
4.3 Sample Size of the Study:
In total there are 46 pharmaceutical firms of listed and non-listed category. Among these 46 are
listed companies. I chose 9 leading firm among those 46 listed firms as the sample of this study.
Sample size16%
Sample Size for the Analysis
70 | P a g e
compliance and noncompliance of IAS in the entire industry. The number of disclosure made by
the pharmaceutical companies in the industry is compared with the other companies in the same
industry. Ultimate goal of all the effort is to conduct the inter industry analysis to justify
compliance of IAS /BAS in industry accounting practice.
4.2 Subject Matter of the Study
The subject matter of the study is about to justify whether firms operating in Bangladesh
pharmaceutical industry (belongs to life science category of comical industry; contributing 35 %
to this broader industry) comply with IAS in their accounting practice or not; if doesn’t comply
then provide explanation against non-compliance with IAS.
4.3 Sample Size of the Study:
In total there are 46 pharmaceutical firms of listed and non-listed category. Among these 46 are
listed companies. I chose 9 leading firm among those 46 listed firms as the sample of this study.
Total DSE and CSEenlisted firms
84%
Sample Size for the Analysis
70 | P a g e
compliance and noncompliance of IAS in the entire industry. The number of disclosure made by
the pharmaceutical companies in the industry is compared with the other companies in the same
industry. Ultimate goal of all the effort is to conduct the inter industry analysis to justify
compliance of IAS /BAS in industry accounting practice.
4.2 Subject Matter of the Study
The subject matter of the study is about to justify whether firms operating in Bangladesh
pharmaceutical industry (belongs to life science category of comical industry; contributing 35 %
to this broader industry) comply with IAS in their accounting practice or not; if doesn’t comply
then provide explanation against non-compliance with IAS.
4.3 Sample Size of the Study:
In total there are 46 pharmaceutical firms of listed and non-listed category. Among these 46 are
listed companies. I chose 9 leading firm among those 46 listed firms as the sample of this study.
Total DSE and CSEenlisted firms
84%
71 | P a g e
4.4. The Pharmaceutical Companies that We Chose to Conduct
Study on Compliance of IAS in Bangladesh Perspective
Since the pharmaceutical industry is prospering day by day and its area of operation expanding
across national boundaries; firm operating within it will face huge complexity in accounting
practice. As most of the countries are now adopting IAS as their accounting standards; the
domestic firm will face difficulty in reporting transaction once for Bangladesh perspective
(BFRS) and once for foreign countries perspective (IAS adopted or compliance BAS). To
resolve these hassle (difficulty in comparability and consistency); now a day most of the firm
adopt IAS besides using BAS. The pace at which industries in Bangladesh are adopting and
complying with IAS indirectly means that “BAS will be engulfed by IAS in near future.
The pharmaceutical companies; that we chose for the study; are all the leading firms in the
industry. The sample size of this study is 9 (that mean I will work on 10 top pharmaceutical
companies as a representative of comical industry (a broader industry)). So the name of 10
sample companies are-
1. Square Pharmaceuticals
2. Incepta Pharmaceuticals
3. Beximco Pharmaceuticals
4. Sun Pharmaceutical (Bangladesh) Ltd
5. ACI Ltd
6. Popular Pharmaceuticals Ltd.
Delta Pharma Ltd
7. IBN SINA Pharmaceutical Industry Ltd.
(IPI)
8. Radiant Pharmaceuticals Ltd
71 | P a g e
4.4. The Pharmaceutical Companies that We Chose to Conduct
Study on Compliance of IAS in Bangladesh Perspective
Since the pharmaceutical industry is prospering day by day and its area of operation expanding
across national boundaries; firm operating within it will face huge complexity in accounting
practice. As most of the countries are now adopting IAS as their accounting standards; the
domestic firm will face difficulty in reporting transaction once for Bangladesh perspective
(BFRS) and once for foreign countries perspective (IAS adopted or compliance BAS). To
resolve these hassle (difficulty in comparability and consistency); now a day most of the firm
adopt IAS besides using BAS. The pace at which industries in Bangladesh are adopting and
complying with IAS indirectly means that “BAS will be engulfed by IAS in near future.
The pharmaceutical companies; that we chose for the study; are all the leading firms in the
industry. The sample size of this study is 9 (that mean I will work on 10 top pharmaceutical
companies as a representative of comical industry (a broader industry)). So the name of 10
sample companies are-
1. Square Pharmaceuticals
2. Incepta Pharmaceuticals
3. Beximco Pharmaceuticals
4. Sun Pharmaceutical (Bangladesh) Ltd
5. ACI Ltd
6. Popular Pharmaceuticals Ltd.
Delta Pharma Ltd
7. IBN SINA Pharmaceutical Industry Ltd.
(IPI)
8. Radiant Pharmaceuticals Ltd
71 | P a g e
4.4. The Pharmaceutical Companies that We Chose to Conduct
Study on Compliance of IAS in Bangladesh Perspective
Since the pharmaceutical industry is prospering day by day and its area of operation expanding
across national boundaries; firm operating within it will face huge complexity in accounting
practice. As most of the countries are now adopting IAS as their accounting standards; the
domestic firm will face difficulty in reporting transaction once for Bangladesh perspective
(BFRS) and once for foreign countries perspective (IAS adopted or compliance BAS). To
resolve these hassle (difficulty in comparability and consistency); now a day most of the firm
adopt IAS besides using BAS. The pace at which industries in Bangladesh are adopting and
complying with IAS indirectly means that “BAS will be engulfed by IAS in near future.
The pharmaceutical companies; that we chose for the study; are all the leading firms in the
industry. The sample size of this study is 9 (that mean I will work on 10 top pharmaceutical
companies as a representative of comical industry (a broader industry)). So the name of 10
sample companies are-
1. Square Pharmaceuticals
2. Incepta Pharmaceuticals
3. Beximco Pharmaceuticals
4. Sun Pharmaceutical (Bangladesh) Ltd
5. ACI Ltd
6. Popular Pharmaceuticals Ltd.
Delta Pharma Ltd
7. IBN SINA Pharmaceutical Industry Ltd.
(IPI)
8. Radiant Pharmaceuticals Ltd
72 | P a g e
CHAPTER 5INDUSTRY RELATED KNOWHOWTHIS CHAPTER WILL COVER:
Pharmaceutical industries knowhow in global perspective Major functions and operation of pharmaceutical industry over the world Pharmaceutical industry growth, importance and contribution in macro perspective Global governing authorities who regulate the action of multinational pharmaceutical
firms Introducing Bangladesh pharmaceutical foot steps toward growth , domestic sufficiency
(in drugs ) and GDP contribution Little knowhow about Bangladesh drugs regulatory authorities Note down major DSE and CSE enlisted firms; playing good in this industry
73 | P a g e
5.0. Introducing with pharmaceutical industry in both global anddomestic prospect
Before proceeding into the depth of the study we should know better about the subject matter andall of its related aspect to find and go through a smooth, accurate and clear-cut ways ofconducting study on this industry. Because in every aspect we first justify an objects externaloutlook then justify the internal aspect. So without knowing the industry; conducting study overthe internal aspect of the industry will be nothing but spending effort and time; which goes intovain.
5.1. Pharmaceutical industry firms, its growth, importance andcontribution in economic growth in the global perspective
The global pharmaceutical market is highly aggressive and is full of entry barriers such as strict
regulations, high R& D cost and time-consuming in case of clinical trials. Besides, high research
and development costs, lengthy clinical trial processes, expiring patents and difficulty in gaining
product authorization from the appropriate regulatory bodies all directly mean that companies
must produce blockbuster drugs to sustain its position in the market. To ensure high growth in
the leading emerging markets; spending on generic drugs is required at first, which will
contribute to the increase in the share of generic spending. Branded products accounted for
nearly two-thirds of global pharmaceutical spending in 2011. However, as patents expire in
developed markets, that share is expected to decline. The growth is coming mainly from market
expansion in the leading emerging countries and from generics.
74 | P a g e
The Top 10 best pharmaceutical companies in 2014 according to global perspective:--
1. PFIZER
2. NOVARTIS
3. HOFFMANN- LA ROCHE
4. JOHNSON & JOHNSON
5. MERCK & CO
6. GLAXO SMITH KLINE
7. SANOFI
8. ELI LILLY
9. ASTRA ZENECA
10. ABBOTT LABORATORIES
At a glance; the highlights of the global pharmaceutical industry is given bellow –
The revenues from generics in 2016 are expected to reach USD 400 to 430 billion,
approximately 70% of which will be outside developed markets
Global brand spending is forecast to increase from USD 596 billion in 2011 to USD in
between 615 to 645 billion in 2016.
The highest growth in this market is being observed in Asia-Pacific
Leading emerging countries will account for 28% of global spending on pharmaceuticals
by 2015, compared to 12% in 2005
Over the next five years growth rate for emerging markets 15 % to 20%, and for matured
markets 6% to 10%
The global pharmaceutical market will reach nearly USD 1200 million by 2016. Global
generic spending is expected to increase from USD 242 billion to USD in between 400 to
430 billion by 2016, of which USD 224-244 billion of the increase is from low-cost
generics in emerging markets.
Blockbuster drugs (with a worth of $150 billion) to lose patents between 2010 and 2017.
Cardiovascular and CNS are the two largest market segments, constituting nearly 38% of
the global generic pharmaceutical market together.
Therapeutic segments such as Respiratory, CNS and Oncology are likely to witness
significantly high growth rates, attracting the attention of market participants.
segments such as Diabetes and Genitourinary/ hormonal drugs are expected to decline
by the 2017
75 | P a g e
Primary activities of the industry are:
1. R&D: Research and development activity is one of the prominent activities to the firm
operating within the industry as well as a strong barrier to potential new entrant. R& D is
a collection of activities directed to development of any new product or process will
ensure the ultimate welfare of the society.
R& D is conducted through systematic process within this industry but model adopted to
conduct R& D may differ firm to firm. There two major and mostly exercised model of
R&D named –
a) In 1st model the primary purpose of conducting research is to developing new
and innovative product
b) In 2nd model R&D is conducted to develop new knowledge and idea which will
add new dimensions in currently exercising science and technologies which in
return will help in the effort of 1st model.
The ultimate goal of conducting R&D is to enhance ROI (return on investment) as well
as reducing cost per unit by reducing VC (variable cost) and FC (fixed cost)
Figure 1.3 (Research and Development)
Designing anddeveloping the
test
75 | P a g e
Primary activities of the industry are:
1. R&D: Research and development activity is one of the prominent activities to the firm
operating within the industry as well as a strong barrier to potential new entrant. R& D is
a collection of activities directed to development of any new product or process will
ensure the ultimate welfare of the society.
R& D is conducted through systematic process within this industry but model adopted to
conduct R& D may differ firm to firm. There two major and mostly exercised model of
R&D named –
a) In 1st model the primary purpose of conducting research is to developing new
and innovative product
b) In 2nd model R&D is conducted to develop new knowledge and idea which will
add new dimensions in currently exercising science and technologies which in
return will help in the effort of 1st model.
The ultimate goal of conducting R&D is to enhance ROI (return on investment) as well
as reducing cost per unit by reducing VC (variable cost) and FC (fixed cost)
Figure 1.3 (Research and Development)
implementstudy to justfyits efficiecy andimprovement
syntesizse andtheorise
Explorehypothesisand clarity
Designing anddeveloping the
test
75 | P a g e
Primary activities of the industry are:
1. R&D: Research and development activity is one of the prominent activities to the firm
operating within the industry as well as a strong barrier to potential new entrant. R& D is
a collection of activities directed to development of any new product or process will
ensure the ultimate welfare of the society.
R& D is conducted through systematic process within this industry but model adopted to
conduct R& D may differ firm to firm. There two major and mostly exercised model of
R&D named –
a) In 1st model the primary purpose of conducting research is to developing new
and innovative product
b) In 2nd model R&D is conducted to develop new knowledge and idea which will
add new dimensions in currently exercising science and technologies which in
return will help in the effort of 1st model.
The ultimate goal of conducting R&D is to enhance ROI (return on investment) as well
as reducing cost per unit by reducing VC (variable cost) and FC (fixed cost)
Figure 1.3 (Research and Development)
syntesizse andtheorise
76 | P a g e
2. Drug Discovery and Development: There are some key point ; representing total effort of
drug discovery and development ;exerted in the global field of this industry; from the
very beginning to the recent time; is given bellow –
The research-based pharmaceutical industry currently spends over USD 135
billion on R&D per year
It takes 10–15 years to develop a medicine.
It costs an average of USD 1.38 billion to develop a single drug
In 2007–2011, the number of new chemical or biological entities launched on the
world market fell to 149 from 196 a decade earlier
In 2011, 5 of the 10 leading global R&D firms were pharmaceutical companies
By the end of 2011 Medicinal product reaches the market, on an average of 12-13
years will have elapsed since the first synthesis of the new active substance.
In 2011, 35 new pharmaceuticals were launched, out of more than 3,200
compounds in development
On average, only one to two of every 10,000 substances synthesized in
laboratories will successfully pass all stages of development required to become a
marketable medicine
The cost of researching and developing a new chemical or biological entity was
estimated at €1,172 million ($ 1,506 million in year 2011 dollars) in 2012
International Drug regulatory authority:
Regulatory authority is exercised either by publicly or privately formed bodies to exert control
over actions of an individual, legal entity or industry sector in such way that those action doesn’t
goes against majority interest or performed in a systematic, relevant and moral way.
Independent regulatory is free from any kind of interfere form ether private and government
operating controls bodies, entities or arms.
Dealing areas of regulatory entity is to assign regulation or enacting rule, principles or code of
conduct for the areas; dealt with by them. Whether a regulatory department is independent is
77 | P a g e
justifies based on existence of some attributes such as – high expertise, rule enforcement
capacity and political interference etc.
A regulatory body may be an executor branch of government, agencies performing audit or
statutory authority.
Some of international impendent drug regulatory authorities are—
I. International Conference on Harmonisation (ICH) for Registration of Pharmaceuticals for
Human Use
II. European Medicines Agency (EMEA)
III. Therapeutic Goods Administration (Australia) (TGA)
IV. U.S. Food and Drug Administration (FDA)
V. Medicines and Healthcare products Regulatory Agency (MHRA)
5.2. Pharmaceutical Industry According to Bangladesh Perspective
Pharmaceutical industry is one of the flourishing hi-tech industries which has high growth, high
future potential and growing market size; results in one of the most competitive industries in
Bangladesh. Although in year 2000; there were around 210 licensed drug manufacturing
companies; among them only 173 is still actively performing within this industry. Rest 37
companies were thrown out from the industry and lost their license due to manufacturing drug
product; which doesn’t comply with drug production rule, regulation, standards and convention.
77 | P a g e
justifies based on existence of some attributes such as – high expertise, rule enforcement
capacity and political interference etc.
A regulatory body may be an executor branch of government, agencies performing audit or
statutory authority.
Some of international impendent drug regulatory authorities are—
I. International Conference on Harmonisation (ICH) for Registration of Pharmaceuticals for
Human Use
II. European Medicines Agency (EMEA)
III. Therapeutic Goods Administration (Australia) (TGA)
IV. U.S. Food and Drug Administration (FDA)
V. Medicines and Healthcare products Regulatory Agency (MHRA)
5.2. Pharmaceutical Industry According to Bangladesh Perspective
Pharmaceutical industry is one of the flourishing hi-tech industries which has high growth, high
future potential and growing market size; results in one of the most competitive industries in
Bangladesh. Although in year 2000; there were around 210 licensed drug manufacturing
companies; among them only 173 is still actively performing within this industry. Rest 37
companies were thrown out from the industry and lost their license due to manufacturing drug
product; which doesn’t comply with drug production rule, regulation, standards and convention.
77 | P a g e
justifies based on existence of some attributes such as – high expertise, rule enforcement
capacity and political interference etc.
A regulatory body may be an executor branch of government, agencies performing audit or
statutory authority.
Some of international impendent drug regulatory authorities are—
I. International Conference on Harmonisation (ICH) for Registration of Pharmaceuticals for
Human Use
II. European Medicines Agency (EMEA)
III. Therapeutic Goods Administration (Australia) (TGA)
IV. U.S. Food and Drug Administration (FDA)
V. Medicines and Healthcare products Regulatory Agency (MHRA)
5.2. Pharmaceutical Industry According to Bangladesh Perspective
Pharmaceutical industry is one of the flourishing hi-tech industries which has high growth, high
future potential and growing market size; results in one of the most competitive industries in
Bangladesh. Although in year 2000; there were around 210 licensed drug manufacturing
companies; among them only 173 is still actively performing within this industry. Rest 37
companies were thrown out from the industry and lost their license due to manufacturing drug
product; which doesn’t comply with drug production rule, regulation, standards and convention.
78 | P a g e
By year 2013 about 300 licensed pharmaceutical firms are operating within the boundary of the
industry. The society is blessed with above 5600 licensed and banded drug products of this
industry. There were, however, 1,495 wholesale drug license holders and about 37,700 retail
drug license holders in Bangladesh.
Whenever “promulgation of Drug Control Ordinance – 1982/ NDP” is enacted and enforced; the
industry growth is became accelerated. Due to rapid development of this sector, the industry is
exporting medicines to global markets. This sector is fulfilling 97% of demand of local market.
The Industry companies also producing drugs such as- insulin, hormones, and anticancer drugs
that wasn’t produced in Bangladesh territory ever before; need to be imported from outside
countries. Recently, new industries have been established with high tech equipment and
professionals to enhance the strength of this sector.
Key points of “promulgation of Drug Control Ordinance – 1982”
1. To provide administrative and legislative support for ensuring quality of essential drugs
which are relevant to the national health need.
2. To reduce the price of medicine by ensuring the lowest competitive price.
3. To eliminate non-essential medicine from the market.
4. To promote production of local drug and raw materials.
5. To develop proper drug monitoring and information system to prevent wasteful misuse and
to ensure the proper utilization of the drugs.
6. To ensure GMP and qualified pharmacist in manufacturing companies.
7. To allot higher budget in research and development sector of this industry
8. To provide tax rebate or subsidy for new or fledging local firms
Consequence of applying Drug controlling ordinance-1982; most of the multinational companies
sold their company to local drug manufacturing companies. According to the website of drug
administration; the value of locally produced drug is increased 175 to 325 cores in between
1981-1985.
79 | P a g e
Drug Regulatory Authorities in Bangladesh
Drug regulatory authorities in Bangladesh are –
1. The Directorate General of Drug Administration (DGDA): DGDA regulates all activities related
to import and export of raw materials, packaging materials, production, sale, pricing,
licensing, registration of all kinds of medicine.
2. The Pharmacy Council of Bangladesh (PCB): PCB was established under the Pharmacy
Ordinance in 1976 to control pharmaceutical industry practice in Bangladesh
Pharmaceutical companies of Bangladesh:
1. Square Pharmaceuticals
2. Incepta Pharmaceuticals
3. Beximco Pharmaceuticals
4. Opsonin Pharma
5. Renata
6. Eskayef Bangladesh
7. ACI Ltd
8. Acme Pharmaceutical
9. Aristopharma
10. Drug International
11. Sanofi-Aventis Bangladesh Ltd
12. GlaxoSmithKline(GSK) Bangladesh
Limited
13. Orion Pharma Ltd
14. Novo Nordisk Healthcare
Pharmaceuticals Limited
15. General Pharmaceuticals Ltd
16. Sandoz (generic pharmaceuticals
division of Novartis)
17. Popular Pharmaceuticals Ltd. (PPL)
18. Novartis (Bangladesh) Limited
19. IBN SINA Pharmaceutical Industry
Ltd. (IPI)
20. Nuvista Pharma Ltd
21. UniMed UniHealth Pharma Ltd
22. Sun Pharmaceutical (Bangladesh) Ltd
23. Globe Pharmaceuticals Ltd
24. BIOPHARMA Ltd
25. Roche Bangladesh Ltd
26. Radiant Pharmaceuticals Ltd
27. Pacific Pharmaceuticals Ltd
28. Jayson Pharmaceuticals Ltd
29. BEACON Pharmaceutical Limited
30. Social Marketing Company (SMC)
31. Orion Infusion Ltd
32. Kemiko Pharmaceuticals Ltd
33. NAVANA Pharmaceuticals Ltd
34. Delta Pharma Ltd
35. Servier Bangladesh
36. SOMATEC Pharmaceuticals Ltd
37. Rangs Pharmaceuticals Ltd
38. Libra Pharmaceuticals Ltd
Scenario, position and growth of the leading firms in past years 2007-2012:
Square is attaining first position in 2012 and Incepta Pharmaceuticals was the second best
competitor. Square’s sale in that particular year was 10.75 billion
Sanofi-Aventis ranked the top among the multinational pharmaceutical companies
Beximco Pharma's position in the country's top 10 pharmaceutical companies was the 3rd
in terms of sales. Its total sales were 4.2 billion in 2009 in taka.
4th position was taken by the ACME Laboratories and its sales were 2.64 billion (in taka)
in 2009.
Opsonin Pharma Ltd was ranked with 5th position based on local sales worth 2.61 billion
(in taka) in 2009.
Eskayef gain 6th position in 2009 by obtaining sale; worth of 2.52 billion (in taka).
8th position was taken by ACI; with a sale of 2.42 billion.
The sales of Aristopharma products were 2.23 billion thus ranked with 9th position
Drug Internationals were 2.13 billion(in taka) and was placed on 10th position in the
local pharmaceutical market
Growth of Bangladesh’s Pharmaceutical Market:
0
5
10
15
20
25
30
2007 2008
Scenario, position and growth of the leading firms in past years 2007-2012:
Square is attaining first position in 2012 and Incepta Pharmaceuticals was the second best
competitor. Square’s sale in that particular year was 10.75 billion
Sanofi-Aventis ranked the top among the multinational pharmaceutical companies
Beximco Pharma's position in the country's top 10 pharmaceutical companies was the 3rd
in terms of sales. Its total sales were 4.2 billion in 2009 in taka.
4th position was taken by the ACME Laboratories and its sales were 2.64 billion (in taka)
in 2009.
Opsonin Pharma Ltd was ranked with 5th position based on local sales worth 2.61 billion
(in taka) in 2009.
Eskayef gain 6th position in 2009 by obtaining sale; worth of 2.52 billion (in taka).
8th position was taken by ACI; with a sale of 2.42 billion.
The sales of Aristopharma products were 2.23 billion thus ranked with 9th position
Drug Internationals were 2.13 billion(in taka) and was placed on 10th position in the
local pharmaceutical market
Growth of Bangladesh’s Pharmaceutical Market:
2009 2010 2011 2012
Scenario, position and growth of the leading firms in past years 2007-2012:
Square is attaining first position in 2012 and Incepta Pharmaceuticals was the second best
competitor. Square’s sale in that particular year was 10.75 billion
Sanofi-Aventis ranked the top among the multinational pharmaceutical companies
Beximco Pharma's position in the country's top 10 pharmaceutical companies was the 3rd
in terms of sales. Its total sales were 4.2 billion in 2009 in taka.
4th position was taken by the ACME Laboratories and its sales were 2.64 billion (in taka)
in 2009.
Opsonin Pharma Ltd was ranked with 5th position based on local sales worth 2.61 billion
(in taka) in 2009.
Eskayef gain 6th position in 2009 by obtaining sale; worth of 2.52 billion (in taka).
8th position was taken by ACI; with a sale of 2.42 billion.
The sales of Aristopharma products were 2.23 billion thus ranked with 9th position
Drug Internationals were 2.13 billion(in taka) and was placed on 10th position in the
local pharmaceutical market
Growth of Bangladesh’s Pharmaceutical Market:
Series1
81 | P a g e
Contribution to national GDP:
GDP (Gross Domestic Product) is the total realized or actual monetary value of all goods, service
and ideas produced , served and generated within a national territory and a specific time period(
usually a year) ether by domestic or multinational firms (firms from outside countries operating
within the national boundary).
GDP is the main indicator of a country’s whole economic proficiency and its better future. The
major contribution in GDP is from the part of industry sector of a country and the value added by
those industries.
Pharmaceutical industry contribution is noteworthy in recent years. The GDP contribution of this
industry from 2005 to 2010 is given bellow-
Source: World Bank World Development Indicators.
Year Growth (%)
2007 15.8
2008 6.9
2009 16.8
2010 23.8
2011 23.6
2012 26.2
Year GDP ( In billion ;U.S dollar)
2005 60.3
2006 61.9
2007 68.4
2008 79.6
2009 89.4
2010 100.3
P a g e | 82
Chapter 6ANALYSIS ON SELCTED HYPOTHIES TO JUSTIFY IASADOPTION AMONG COMPANIESOBJECTIVE OF THIS CHAPTER IS TO:
Develop the questions came in researcher’s mind relevant to IAS adoption
Creating relevant hypothesis based on relevant question about IAS adoption
Creating checklists , graph, calculation , and proving interpretation / illustration toback up the hypothesis that I will develop
Try best to conduct analysis in an understandable and friendly way ; so that anybodycan easily realize the martial that will provided inside this part
We will conduct analysis in this part as well as notes down the findings of analysis
P a g e | 82
Chapter 6ANALYSIS ON SELCTED HYPOTHIES TO JUSTIFY IASADOPTION AMONG COMPANIESOBJECTIVE OF THIS CHAPTER IS TO:
Develop the questions came in researcher’s mind relevant to IAS adoption
Creating relevant hypothesis based on relevant question about IAS adoption
Creating checklists , graph, calculation , and proving interpretation / illustration toback up the hypothesis that I will develop
Try best to conduct analysis in an understandable and friendly way ; so that anybodycan easily realize the martial that will provided inside this part
We will conduct analysis in this part as well as notes down the findings of analysis
P a g e | 82
Chapter 6ANALYSIS ON SELCTED HYPOTHIES TO JUSTIFY IASADOPTION AMONG COMPANIESOBJECTIVE OF THIS CHAPTER IS TO:
Develop the questions came in researcher’s mind relevant to IAS adoption
Creating relevant hypothesis based on relevant question about IAS adoption
Creating checklists , graph, calculation , and proving interpretation / illustration toback up the hypothesis that I will develop
Try best to conduct analysis in an understandable and friendly way ; so that anybodycan easily realize the martial that will provided inside this part
We will conduct analysis in this part as well as notes down the findings of analysis
P a g e | 83
6.0. Brief Discussion about the Research Procedure and Road Map of the
Study:
Before proceeding into analysis we first develop hypothesis and throughout the research we will
try to proof the hypothesis that we presumed before. We may develop several hypotheses and
several methods as well; based on situation. Sometime we may use some statistical software to
find out relation among variable of the hypothesis. In the whole part of the research we may
adopt qualitative and quantitative research method based on situational demand.
Step of the research will go through a systematic and sequential way as follow –
1. Develop questions that comes in my mind about the issues related with IAS compliance
2. Develop hypothesis ; which is just a narrative form answer of the question according to
our perception
3. Selecting sample size based on which we will analyze the validity of our hypothesis
4. Determine dependent and independent variable
5. Arranging data into understandable form and presenting them in checklist
6. Reduce unnecessary data if any and then made reasoning on those data
7. Representing them in graphical or other visual format to made the results understandable
to general people
8. Framing the findings in theoretical format
9. Giving judgments and decision
P a g e | 84
6.1. Topic of the Research
Now a day Bangladesh national accounting policies are reforming to made a bridge with IAS /
IFRS rules. Bangladesh accounting standard setting bodies prescribes each and every firm
operating within different industries to follow IAS or IFRS. So we are interested to conduct
research to justify the topic “international accounting standard compliance in pharmaceutical
industry- a case of Bangladesh” to get the idea about whether or not Bangladesh industries has
practicing renovated and reinforced national standards ( BAS)
6.2. The research on IAS Compliance in Bangladesh pharmaceutical
Industries
All the research phases will be describe in sequentially and organized order given in very
beginning of this chapter
6.3. Developing Questions Reflecting IAS Compliance
1. Did every pharmaceutical firm represent their financial statement in accordance with
IAS 1 prescribed manner?
2. Does Adoption of IAS 16 through using different deprivation method affect PPE
Turnover, NI and Tax Return of the companies?
3. Does IAS compliance in consistent manner and comparability of financial statementsamong selected companies have a positive relation?
P a g e | 85
6.4. Develop Hypothesis (assumptions) for the Research
H1: the companies create and represent their financial statement in accordance with IAS1
H2: Adoption of IAS 16 through using different deprivation method somehow affect PPE
Turnover, NI and Tax Return of the companies
H3: IAS compliance in consistent manner and comparability of financial statements
among selected companies has a positive relation
6.5.0 Analyze Hypothesis No.1 (Compliance with IAS 1)
6.5.1Defining Variables
Variable that are required to proof our first hypothesis are –
Variable Variable identification
Dependent variable Overall industry percentage of compliance with IAS
Independent variable Company’s respective compliance score
6.5.2. Independent Variable Scoring Procedures
Item No.3
Item No.2
Item no.3
Comparedwith relatedrules in IAS
Compared
Notcompared
Item 1
Item 2
Item 3
Value =1
Value=1
Value =0
Item.4Partiallycompared Item 4
Value=0.5
P a g e | 86
Figure: Assigning value to the items representing variables
When we compare different element of financial statement with rules of IAS -1 then –
If those item complied with respective IAS rules then the value assigned to that complied
item will be 1
If the item doesn’t comply with respective IAS rules then the value assigned to those item
will be 0
When some item doesn’t fully comply with relevant IAS rules then the assigned value to
the dependent variable will be 0.5
Company Codes For Analytical Purpose :
C1= Square Pharmaceuticals C6= Popular Pharmaceuticals Ltd. (PPL)
C2= Incepta Pharmaceuticals C7= Delta Pharma Ltd
C3= Beximco Pharmaceuticals C8= Sun Pharmaceutical (Bangladesh) Ltd
C4= IBN SINA Pharmaceutical Industry Ltd. C9= Radiant Pharmaceuticals Ltd
C5= ACI Ltd
Qualitative explanationcriteria on the IAS -1compliance scores
P a g e | 86
Figure: Assigning value to the items representing variables
When we compare different element of financial statement with rules of IAS -1 then –
If those item complied with respective IAS rules then the value assigned to that complied
item will be 1
If the item doesn’t comply with respective IAS rules then the value assigned to those item
will be 0
When some item doesn’t fully comply with relevant IAS rules then the assigned value to
the dependent variable will be 0.5
Total compliancescore will be
execelent whenin between 90-
100%complianceensured
If total scorewill be in
between 70-90%then very good
complinace
If total score isless than 50%
then thecompany will bescored as poor inIAS compliance
If totalcompliance is in
between 50-70% then
moderatelygood or good
complaince withIAS
Company Codes For Analytical Purpose :
C1= Square Pharmaceuticals C6= Popular Pharmaceuticals Ltd. (PPL)
C2= Incepta Pharmaceuticals C7= Delta Pharma Ltd
C3= Beximco Pharmaceuticals C8= Sun Pharmaceutical (Bangladesh) Ltd
C4= IBN SINA Pharmaceutical Industry Ltd. C9= Radiant Pharmaceuticals Ltd
C5= ACI Ltd
Qualitative explanationcriteria on the IAS -1compliance scores
P a g e | 86
Figure: Assigning value to the items representing variables
When we compare different element of financial statement with rules of IAS -1 then –
If those item complied with respective IAS rules then the value assigned to that complied
item will be 1
If the item doesn’t comply with respective IAS rules then the value assigned to those item
will be 0
When some item doesn’t fully comply with relevant IAS rules then the assigned value to
the dependent variable will be 0.5
Company Codes For Analytical Purpose :
C1= Square Pharmaceuticals C6= Popular Pharmaceuticals Ltd. (PPL)
C2= Incepta Pharmaceuticals C7= Delta Pharma Ltd
C3= Beximco Pharmaceuticals C8= Sun Pharmaceutical (Bangladesh) Ltd
C4= IBN SINA Pharmaceutical Industry Ltd. C9= Radiant Pharmaceuticals Ltd
C5= ACI Ltd
Qualitative explanationcriteria on the IAS -1compliance scores
P a g e | 87
6.5.3. Arranging Data into Checklist (Based on Annual Reports of 2013)
Related
IAS
Facts to be compared C1 C2 C
3
C
4
C
5
C
6
C
7
C
8
C9
IAS
1.25
Financial is not prepared in accordance with
GAAP the disclose--
(a) Existence of factors arising doubt about GC 0 0 0 0 0 0 0 0 0
(b) Basis of FS preparation 1 1 1 1 1 1 1 1 1
(c) Discloser about not following GC 0 0 0 0 0 0 0 0 0
IAS
1.27
Accrual basis accounting
Prepare all FS in accrual basis except CF
statement
1 1 1 1 1 1 1 1 1
IAS
1.10
Structural constant:
A complete set of FS comprise -
(a) Statement of FP 1 1 1 1 1 1 1 1 1
Statements of CF 1 1 1 1 1 1 1 1 1
(c) Statements of change in equity 1 1 1 1 1 1 1 1 1
(b) Statements of comprehensive income 1 1 1 1 1 1 1 1 1
(e) Notes to the FS 1 1 1 1 1 1 1 1 1
(f) Apply accounting policy retrospectively 1 1 1 1 1 1 1 1 1
IAS
1.31
Clearly identify and distinguish
information of FS
1 1 1 1 1 1 .5 .5 .5
IAS
1.49
Material fact are need to be disclosed 1 1 1 1 1 1 1 1 1
IAS
1.51
Clearly identify each FS and notes 1 1 1 1 1 1 .5 .5 1
IAS
1.51
Disclose necessaries to provide clear
understanding --
(a) Name of the reporting entity 1 1 1 1 1 1 1 1 1
P a g e | 88
(b) Whether individual or group entity 1 1 1 1 1 .5 1 .5 .5
(c) Date of the end of reporting period and
staring reporting period
1 1 1 1 1 1 1 1 1
(e) Presentation currency 1 1 1 1 1 1 1 .5 .5
(f) Level rounding fraction is used in FS
amounts
0 0 0 0 0 0 0 0 0
IAS
1.36
Present complete set of FS at least annually 1 1 1 1 1 1 1 1 1
1.36 When entity change its reporting period
(RP)
0 0 0 0 0 0 0 0 0
1.36 Reason of using longer or shorter RP 0 0 0 0 0 0 0 0 0
1.36 Disclose about why comparative amount
are not totally comparable
0 0 0 0 0 0 0 0 0
Statements of Financial position
IAS
1.60
Current –non Current distinction : assets
and liability are arranged in order of
liquidity and categories into spate section
1 1 1 1 1 1 1 1 1
IAS
1.32
Asset and liabilities will not offset unless
required by IFRS
1 1 1 1 1 1 1 1 1
IAS
1.29
Each material class with similar arranged in
similar section
1 1 1 1 1 1 1 1 1
1.29 Item with dissimilar nature will recorded
separately ( if immaterial)
1 1 1 1 1 .5 1 .5 1
IAS
1.54
Statement of Financial position should
include following items ( at least)
(a) Property , plant and equipment 1 1 1 1 1 1 1 1 1
(b) Investment property 1 1 1 1 1 1 1 1 1
(b) Intangible asset 1 1 1 1 1 1 1 1 1
(c) Financial assets 1 1 1 1 1 1 1 1 1
(d) Investment ( recorded as equity method ) 1 1 1 1 1 1 1 1 1
P a g e | 89
(e) Biological assets 0 0 0 0 0 0 0 0 0
(f) Inventories 1 1 1 1 1 1 1 1 1
(g) Trade and other receivable 1 1 1 1 1 1 1 1 1
(h) Cash and cash equivalent 1 1 1 1 1 1 1 1 1
IFRS
5.38
Total assets held for sale included in
disposal group
1 1 1 1 1 1 .5 .5 .5
IAS
1.54
Trade and other payable 1 1 1 1 1 1 1 1 1
1.54 Cash and cash equivalent 1 1 1 1 1 1 1 1 1
1.54 Provisions 1 1 1 1 .5 1 .5 .5 1
1.54 Financial liabilities ( excluding trade
payable and provisions)
1 1 1 .
5
1 1 1 1 .5
1.54 Liabilities and asset for current tax 1 1 1 1 1 1 1 1 1
1.54 Deferred tax liabilities and assets 1 1 1 1 1 1 1 1 1
1.54 Non-controlling interest ( presented with
equity excluding parent’s )
1 1 1 1 1 1 1 1 1
IAS
1.78
Disclose in notes
(a) Items of PPE 1 1 1 1 1 1 1 1 1
(b) Receivables 1 1 1 1 1 1 1 1 1
(c) Inventories sub classified 1 1 1 1 1 1 1 1 1
(d) Provisions 1 1 1 1 .5 1 1 .5 1
Equity capital and reserve 1 1 1 1 1 1 1 1 1
IAS
1.79
Discloser in SOFP
I. Number of share authorized 1 1 1 1 1 1 1 1 1
II The number of share outstanding 1 1 1 1 1 1 1 1 1
III Share per value 1 1 1 1 1 1 1 1 1
IV Reconciliation of number of outstanding
share at the end of the reporting period
1 1 1 1 1 1 1 1 1
P a g e | 90
IAS
20.24
Discloser about government grant related
assets ( including Non-monetary grants ) as
either
(a) Deferred income 0 0 0 0 0 0 0 0 0
(b) Deduction in arriving at the BV of assets 0 0 0 0 0 0 0 0 0
Statements of comprehensive Income
IAS
1.81
Present all income and expenses in ether -
(a) A single statement displaying
comprehensive income
1 1 1 1 1 1 1 1 1
(b) Two statement ( income statement
+statement of other CI)
--- --- - -- -- -- -- --
IAS
1.12
Income sate should be presented immediate
before the statement of other CI (IAS
1.81(b))
0 0 0 0 0 0 0 0 0
IAS
1.32
Income and expense are not offset unless
required by IFRS
1 1 1 1 1 1 1 1 1
IAS
1.88
Include all the items of income and expense
recognized in the period of P/L
1 1 1 1 1 1 1 1 1
IAS
1.29
Classify similar item under a defined title 1 1 1 1 1 1 1 1 1
IAS
1.82
The statement of comprehensive income
should include the following items --
(a) Revenue 1 1 1 1 1 1 1 1 1
(b) Financial cost 1 1 1 1 1 1 1 1 1
(C) Share of profit / loss associated with joint
venture
1 1 1 1 1 .5 .5 1 .5
(d) Tax expense 1 1 1 1 1 1 1 1 1
(e) Profit/loss 1 1 1 1 1 1 1 1 1
(f) Share of other comprehensive income 1 1 1 1 .5 .5 1 .5 1
P a g e | 91
associated with joint venture
(g) Total comprehensive income 1 1 1 1 1 1 1 1 1
IAS
1.83
Discloser in the statement of CI
(a) Profit or loss attributable
(I)NCI 1 1 1 1 1 1 .5 .5 1
(II) Owner’s of the parents 1 1 1 1 1 1 1 1 1
(b) Total comprehensive income for the period
attributable to
(I)NCI 1 1 1 1 1 1 1 .5 1
(II) Group reserve 1 1 1 1 1 1 1 1
IAS
1.91
Present component of other CI ether
(a) Net of related tax effect 1 1 1 1 1 1 1 1 1
(b) Before tax effect with one amount of
income tax relating to those companies
- - - - - - - - -
IAS
20.29
Govt. grant related income are presented as
ether ---
(a) Separately under general heading “other
income”
1 1 1 1 1 1 1 1 1
(b) Deducted in reporting the related expenses - - - - - - - - -
IAS
1.106
Actuarial gain or losses are recognized in
other CI
1 1 1 1 1 1 1 0 0
IAS
33.6
Present basic and diluted EPS 1 1 1 1 1 1 1 1 1
IAS
1.98
Circumstance that requires separate
discloser
(a) Write-down of inventories to NRV 1 1 1 1 1 1 1 1 1
(b) Disposal of PPE 1 1 1 1 1 1 1 1 1
(c) Disposal of investment 1 1 1 1 1 1 1 1 1
P a g e | 92
(d) Discounted operation 1 1 1 1 1 1 1 1 1
(e) Litigation settlement 0 0 0 0 0 0 0 0 0
(f) Other reversal of provision 1 1 1 1 1 1 1 1 1
(g) Other reversal of provision 1 1 1 1 .5 1 .5 .5 .5
IAS
1.90
Disclose the amount of income tax relating
to each component of other comprehensive
income
1 1 1 1 1 1 1 1 .5
Change in Equity statement
IAS
1.29
Each similar item are classified and
presented separately
1 1 1 1 1 1 1 1 1
IAS
1.29
Dissimilar item are also need to be
presented separately when those are
immaterial
1 1 1 1 1 1 1 1 1
IAS
1.30
Material item should be reported ether in
statement of change in equity or notes
1 1 1 1 1 1 1 1 1
IAS
1.31
Required to present specific discloser
required by IFRS
1 1 1 1 1 1 1 1 1
IAS
1.106
Statement of change in equity should
include the following item (recommended )
1 1 1 1 1 1 1 1 1
(a) Total comprehensive income 1 1 1 1 1 1 1 1 1
(b) Retrospective application to the each
component of equity
1 1 1 1 1 1 1 1 1
(c) Disclosing change in profit/loss , other CI ,
transactions with owners
1 1 1 1 1 1 1 1 1
IAS
1.10A
Present each component of equity ether in
statement of change in equity or notes
1 1 1 1 1 1 1 1 1
IAS
1.108
The component of equity is accumulated
balance of each class of other
comprehensive income and retained
earning
1 1 1 1 1 1 1 1 1
P a g e | 93
Statement of cash flow
IAS
1.29
Each similar item with same nature should
presented separately in CF statement
1 1 1 1 1 1 1 1 1
IAS
1.29
Each dissimilar item are presented
separately ( if not material)
1 1 1 1 1 1 1 1 .5
IAS
1.30
Material item should be reported ether in
statement of CF or notes
1 1 1 1 1 1 1 .5 .5
IAS
1.06A
CF statement should be made in direct or
indirect way and there should be
representation of operational activities ,
investment activities and financial activities
1 1 1 1 1 1 1 1 1
Company’s respective score in compliance of IAS prescribed way in preparation and
representation of four major financial statements will be shown in the table given bellow. We
will assign score based on how much the company score in compliance with total relevant IAS
items in each financial statement section (whereby denominator is the full compliance score; for
example- there are 4 IAS item and if a company comply 2 item then the company’s score will be
.5(2/4) ). For ease in calculation we will round off up to two decimal.
Identity of
Financial
Statement
C1 C2 C3 C4 C5 C6 C7 C8 C9
Consolidated
financial
statement
(29/32)
=.91
(29/32)
=.91
(29/32)
=.91
(28.5/3
2)
=.89
(28/32)
=.88
(28.5/3
2)
=.89
(28/32)
=.88
(27/32
)
=.84
(28/3
2)
=.88
Statement of
comprehensi
ve income
(26/28)
=0.93
(26/28)
=.93
(27/28)
=.96
(25/28)
=.89
(25/28)
=.89
(26/28
)
=.93
(25.5/28
)
=.91
(24/28
)
=.86
(23.5/
28)
=.84
P a g e | 94
Statement of
change in
equity
(10/10)
=1
(10/10)
=1
(10/10)
=1
(10/10)
=1
(10/10)
=1
(10/10
)
=1
(10/10)
=1
(10/10
)
=1
(10/1
0)
=1
Statement
of change in
Cash Flow
(4/4)
=1
(4/4)
=1
(4/4)
=1
(4/4)
=1
(4/4)
=1
(4/4)
=1
(4/4)
=1
(3.5/4)
=.88
(3/4)
=.75
Basic/
general
compliances
(16/22)
=.72
(16/22)
=.72
(16/22)
=.72
(16/22)
=.72
(16/22)
=.72
(15.5/2
2)
=.70
(15/22)
=.68
(14/22
)
=.63
(14.5/
22)
=..66
Now we will use these summarized data to represent the IAS-1 compliance into many
dimension. First the thing that we want to justify is IAS-1 compliance in case of presentation,
preparation, reporting and illustrating Balance sheet, Cash Flow, Change in equity and
Comprehensive Income statement items and other accounting policies regarding these major
financial statement. We also concerned about to see major general compliance (which is
common for all companies operating in different industries, geographical location and economic
atmosphere) with IAS-1
Companycodes
ConsolidatedFinancial
Statement itemscompliance with
IAS-1
Comprehensiveincome
statement itemscompliance with
IAS-1
Change inEquity statement
itemscompliance with
IAS-1
Cash Flowstatement itemscompliance with
IAS-1
Generalcompliances
of IAS-1
C1 0.91 0.93 1 1 0.72C2 0.91 0.93 1 1 0.72C3 0.91 0.96 1 1 0.72C4 0.89 0.89 1 1 0.72C5 0.88 0.89 1 1 0.72C6 0.89 0.93 1 1 0.7C7 0.88 0.91 1 1 0.68C8 0.84 0.86 1 1 0.63C9 0.88 0.84 1 0.88 0.66
Source: own calculation
P a g e | 95
If we graphically depict individual company compliance scenario with IAS-1 then this will
looked as like as given bellow-
Source: own calculation
Information is implicitly included in those graphical line movements are as follow –
1. All the companies fully comply with IAS-1 case of preparing statement of change of
equity. so we can forecast that company fully disclose all relevant trisection that
influence a company’s equity in full and apparent manner
2. In case of preparing comprehensive income statement we observe a huge fluctuation in
compliance with IAS-1 among those companies. Which mean some company fight shy
some of IAS-1 rules which ether not adopted by ICAB or is obsolete in this particular
industry or compliance of those compromised IAS-1 rules is situational based which
are not incurred in 2013 ( result in avoidance of them)
3. There are several ways to create consolidating financial statement and many
contingent issues exist in the time of creating it. For example : if less than 20%
ownership interest is possessed by investee then follow cost method ;otherwise follow
equity method / consolidation ( in case of above 20% or above 50% respectively ). So
there are also fluctuation is seen apparently in the graph representing consolidated
financial statement compliance with IAS-1
0
0.2
0.4
0.6
0.8
1
1.2
C1 C2 C3 C4 C5 C6 C7 C8 C9
Consolidated FinancialStatement items compliance withIAS-1
Comprehensive income statementitems compliance with IAS-1
Chage in Eqiity statement itemscompliance with IAS-1
Cash Flow statement itemscompliance with IAS-1
General compliancse of IAS-1
P a g e | 96
4. All the companies except C8 and C9 follow the IAS-1 prescribed guideline in
preparation of Cash Flow statement. Since C8 and C9 follow indirect approach to
record cash follow statement related item so some of IAS-1 rules which usually deal
with adoption of direct method has overlooked by the companies( consequently scored
less in comparative to other companies)
5. Summary and comments according to dependent variable scoring criteria ( that has
give in a clip art at the very beginning of the analysis part)
Description IAS-1 Compliance in scoring
range
Comment in short
Preparation Consolidated
Financial Statement
compliance over the industry
sample
Ensure 85-95% compliance
(graph line is positioned in
between 1 and 0.8; so we
average it =0.9. To ensure
accuracy we just expressed
the average as 0.9±0.05)
Excellent
compliance ( best
compliance score in
range)
Very Good
compliance for
lowest compliance
score( %) in range
Preparation Cash flow
Statement compliance over
the industry sample
Ensure 77.5-92.5%
compliance (graph line is
positioned in between 1 and
0.75; so we average it
=0.875. To ensure accuracy
we just expressed the
average as 0.875±0.05)
Excellent
compliance ( best
compliance score in
range)
Very Good
compliance for
lowest compliance
score( %) in range
P a g e | 97
Preparation Comprehensive
Income Statement
compliance over the industry
sample
Ensure 80-90% compliance
(graph line is positioned in
between .8 and 0.9; so we
average it =0.85. To ensure
accuracy we just expressed
the average as 0.85±0.05)
Very good
compliance ( based
on lowest and best
compliance score in
range
Preparation Change in Equity
Statement compliance over
the industry sample
Companies ensure 99-100%
compliance. Compliance rate
is so high because company ,
their auditor and other
authorities are used to
rigorously maintain
transparency in capital and
equity item because
stockholders are strongly
based on those information
Excellent
compliance ( based
on lowest and
highest compliance
score in range)
General or Basic compliance
over the industry sample
Ensure 62.5-72.5%
compliance (graph line is
positioned in between 0.65
and 0.7; so we average it
=0.675. To ensure accuracy
we just expressed the
average as 0.675±0.05)
Very good
compliance ( best
compliance score in
range)
Good compliance
(based lowest
compliance score in
range)
Source: own analytical justification
P a g e | 98
Now we want to see the percentage of total compliance in presenting each type of financialstatements; covered by IAS-1
Particulars
Average score ofall companies
Total score of allfinancial statement
compliance ifIAS-1 fully
applied
Share in total scoreof all financial
statementcompliance In percentage
ConsolidatedFinancial
Statement itemscompliance with
IAS-1 0.887526393 5 0.18 18%Comprehensive
income statementitems compliance
with IAS-1 0.903723278 5 0.18 18%Change in Equitystatement itemscompliance with
IAS-1 1 5 0.2 20%Cash Flow
statement itemscompliance with
IAS-1 0.985896689 5 0.20 20%General
compliances ofIAS-1 0.695941376 5 0.14 14%
% of compliancewith IAS-1 of all
companies intotal compliancescore ( achieved
when fullycomplied with
IAS-1) 4.473087737 5 0.89 89%
Source: own calculation
P a g e | 99
To illustrate the table a pie chart is given bellow –
Compliance of IAS-1 in preparation of different financial statement is equally allocated. So
dispersion among scores in each area of interest is less. That means company equally exercises
IAS-1 in case of preparing consolidated financial statement, comprehensive income, cash flow
statements, and statement of change in equity.
Chage in Eqiitystatement items
compliance with IAS-122%
Cash Flowstatement itemscompliance with
IAS-122%
Generalcompliancse of
IAS-116%
Share of Each Finacial Satement And GeneralComplinace With Total Compliace Score in The Scale
of Five
P a g e | 99
To illustrate the table a pie chart is given bellow –
Compliance of IAS-1 in preparation of different financial statement is equally allocated. So
dispersion among scores in each area of interest is less. That means company equally exercises
IAS-1 in case of preparing consolidated financial statement, comprehensive income, cash flow
statements, and statement of change in equity.
ConsolidatedFinancial Statement
items compliancewith IAS-1
20%
Comprehensiveincome statement
items compliance withIAS-120%
Share of Each Finacial Satement And GeneralComplinace With Total Compliace Score in The Scale
of Five
P a g e | 99
To illustrate the table a pie chart is given bellow –
Compliance of IAS-1 in preparation of different financial statement is equally allocated. So
dispersion among scores in each area of interest is less. That means company equally exercises
IAS-1 in case of preparing consolidated financial statement, comprehensive income, cash flow
statements, and statement of change in equity.
ConsolidatedFinancial Statement
items compliancewith IAS-1
20%
Comprehensiveincome statement
items compliance withIAS-120%
Share of Each Finacial Satement And GeneralComplinace With Total Compliace Score in The Scale
of Five
P a g e | 100
Findings:
All the firms exercise IAS-1 in case of representing financial statement
Higher compliance in case of presenting and creating Cash Flow Financial Statement and
Statement of Change in Equity 44% of total compliance
Second higher compliance in case of preparing and presenting Consolidated Financial
Statement and Comprehensive Income Statements whereby the companies ensure 40% of
total compliance ( combined score 40% )
Lowest compliance in case of applying 16% of total compliance in practicing general
accounting practice reported and recommended by IAS-1
6.5.4. Decision Making
H1: The companies create and represent their financial statement in accordance withIAS-1 (became true)
H0: The companies don’t create and represent their financial statement in accordancewith IAS-1 (doesn’t support by analysis and proved as wrong statement)
P a g e | 101
6.6. Verifying “Hypothesis 2” (Adoption of IAS 16 through Using DifferentDeprivation Method Somehow Affect PPE Turnover, NI and Tax Return ofthe Companies)
6.6.1. Introductory Discussion
Property plant and equipment represents substantial investments particularly to manufacturing,
extractive and telecommunication companies. The method of recognition and measurement for
such assets can have significant impact on the profitability of the firm. In this article, I examine
the intensity of Property Plant and Equipment, the depreciation methodology and the overall
impact on profitability.
As per IAS 16, PPE can be defined as tangible assets that are held for use in the production or
supply of goods and services or for rental to others, or for administrative purposes and are
expected to be used during more than one accounting period (more than one year). Ex-ante, a
company spends an initial investment to purchase this asset with the hope that, these assets will
generate, or facilitate in the generation of income (in the economic sense of it). Once recognized
in the statement of financial position, an entity needs to provide for depreciation i.e. spread the
cost of the asset over its estimated useful life taking into account any residual value. The
common methods of charging depreciation are the straight-line method, the diminishing balance
method the sum of the year’s digits method and the units of production method. The methods of
depreciation accounting differs from firm to firm, but in the long run, irrespective of the
accounting method used, the net effect on the financial statement should be the same. However, a
problem arises when companies’ profits are compared with each other in the short run given that
the amount of depreciation can distort profit levels.
P a g e | 102
A review of the financial statements of Pharmaceutical firms reveals that a majority prefer the
straight-line method of charging depreciation as opposed to the diminishing balance method. The
rationale of the straight-line method of depreciation is that, an equal amount of the assets useful
life is consumed on an annual basis. This results in a constant depreciation charge for the assets
over the assets useful life provided there are no revaluations or major improvements to the asset
in the following accounting period. The advantage to this method is that, it is easy to understand
and apply in practice hence many professional accountants prefer this method to the diminishing
balance method. Another reason for its popularity is that, it is a tool of gauging stable profits
over the years as there is no variability in the depreciation expense. The hind side of this method
is that, for some assets, businesses turn to use them more when the asset is new than when it gets
older. For some industries, the seasonal nature of it may require more usage of the asset when
demand peaks (Fared& Danial; 2001). This will mean that, there is an under charge for
depreciation in that year when the asset is over used that in period when the asset is idle.
6.6.2. Justifying and Analyzing Hypothesis 4
To justify hypothesis (4) we create a simulated scenario given bellow---
Depicted scenario to justify H4:
For example supposes company “A” buys a machine for 10,000 and the estimated useful life of
the asset is 10 years without any residual value. For justify the influence on turnover we set
Revenue 100000 in every of 10 year consistently; increasing or decreasing it by 2000 in other 2
scenario. The annual depreciation charge of 10, 00 is charged as an expense to the income
statement as see from the table below.
P a g e | 103
Straight Line Depreciation Scenario
Revenueassumed
decreasingby 2000
constantly
Revenueassumed
inceasing by2000
constantly
Revenueassumedconstant
Net BV orending PPE
PPEturnover forconstant
PPEturnover forincreasingrevenue
PPEturnover fordeceasingrevenue
98000 102000 100000 9000 11.111111 11.333333 10.88888996000 104000 100000 8000 12.5 13 1294000 106000 100000 7000 14.285714 15.142857 13.42857192000 108000 100000 6000 16.666667 18 15.33333390000 110000 100000 5000 20 22 1888000 112000 100000 4000 25 28 2286000 114000 100000 3000 33.333333 38 28.66666784000 116000 100000 2000 50 58 4282000 118000 100000 1000 100 118 8280000 120000 100000 0 Nill Nill Nill
Table: Straight line depreciation impact on PPE turnover
Straight-line Method Depreciation Charges
Year Annual Depreciation Charge Net Book Value Accumulated Depreciation1 1,000 9000 10002 1,000 8000 20003 1,000 7000 30004 1,000 6000 40005 1,000 5000 50006 1,000 4000 60007 1,000 3000 70008 1,000 2000 80009 1,000 1000 9000
10 1,000 0 10000Source: Own Calculations
P a g e | 104
Revenueassumed
decreasingby 2000
constantly
Revenueassumedincreasing
by2000
constantly
Revenueassumedconstant
DepreciationinSL method
(C)EarningBeforeTax forconstant
(I)EBT forincreasing
Revenue
(D)EBT fordecreasing
Revenue98000 102000 100000 1000 99000 101000 9700096000 104000 100000 1000 99000 103000 9500094000 106000 100000 1000 99000 105000 9300092000 108000 100000 1000 99000 107000 9100090000 110000 100000 1000 99000 109000 8900088000 112000 100000 1000 99000 111000 8700086000 114000 100000 1000 99000 113000 8500084000 116000 100000 1000 99000 115000 8300082000 118000 100000 1000 99000 117000 8100080000 120000 100000 1000 99000 119000 79000
Table: Straight line depreciation impact on PPE turnover, NI and Tax return
Tax effect in Straight line depreciation method
(C)tax 20%
(D)tax@20%
(I)tax @20%
(C)NI
(D)NI
(I)NI
19800 19400 20200 79200 77600 8080019800 19000 20600 79200 76000 8240019800 18600 21000 79200 74400 8400019800 18200 21400 79200 72800 8560019800 17800 21800 79200 71200 8720019800 17400 22200 79200 69600 8880019800 17000 22600 79200 68000 9040019800 16600 23000 79200 66400 9200019800 16200 23400 79200 64800 9360019800 15800 23800 79200 63200 95200
Notes: This table has relation with the table given above
P a g e | 105
PPE turnover scenario in SL depreciation method:
Change in PPE turnover in different simulated condition and in different fiscal year in the
straight-line depreciation will graphically looked like as follow –
Illustration:
if the depreciation is determined in accordance with SL depreciation method then the
companies will face a gradual increase in PPE turnover over 8 year and will reach in
peak in PPE turnover in 9th year of total useful life of PPE (10year).in last year of useful
life of PPE; the PPE will became 0 because there are no residual value of PPE left.
Ultimate finding is that “company can gain growing PPE return although its revenue is in
increasing, decreasing and constant situation.
0
50
100
150
200
250
300
350
1 2 3 4 5 6 7 8 9 10
PPEturnover for deceasing revenue
PPEturnover for increasing revenue
PPEturnover for constant
P a g e | 106
EBT Scenario in SL depreciation method:
Illustration:
If revenue of the companies are kept constant then the EBT will be go through a leaner
direction that mean the company will face consistent profit over the 10 year of useful life
of PPE
If revenue of the companies are kept increasing constantly by 2000 in each year then the
EBT will be go through a upward direction that mean the company will face increasing
profit over the 10 year of useful life of PPE
If revenue of the companies are kept deceasing constantly by 2000 in each year then the
EBT will be go through a downward direction( but at too lesser extent) that mean the
company will face little decrease in profit over the 10 year of useful life of PPE
0
50000
100000
150000
200000
250000
300000
350000
1 2 3 4 5 6 7 8 9 10
(D)EBT fordecreasing Revenue
(I)EBT forincreasing Revenue
(C)Earningbefore tax for constant
P a g e | 107
The ultimate finding is that “ SL depreciation method gives a consistent profit over the
year and thus ensuring transparency in profit as well as ease in calculating tax return
Tax scenario in SL depreciation method:
Illustration:
If revenue of the companies are kept constant then the tax will be go through a leaner
direction that mean the company will face consistent tax return over the 10 year of useful
life of PPE
If revenue of the companies are kept increasing constantly by 2000 in each year then the
tax return of the companies will be go through a upward direction that mean the
company will face mostly constant tax( with a slight decrease) return over the 10 year of
useful life of PPE
0
10000
20000
30000
40000
50000
60000
70000
1 2 3 4 5 6 7 8 9 10
(I) tax@20%
(D) tax@20%
(C)tax 20%
P a g e | 108
If revenue of the companies are kept deceasing constantly by 2000 in each year then the
Tax Return will be go through a downward direction( but at greater extent) that mean
the company will face greater decrease in tax return over the 10 year of useful life of
PPE
The ultimate finding is that “ SL depreciation method gives a consistent tax provision
over the year in case of constant and increasing revenue and a good cut of tax return in
case of decreasing revenue thus ensuring good profitability of the companies as well as
help in case downturn years
Net Income scenario in Straight Line depreciation system:
Illustration:
If revenue of the companies are kept constant then the NI will be go through a leaner
direction that mean the company will face consistent NI over the 10 year of useful life
of PPE
0
50000
100000
150000
200000
250000
1 2 3 4 5 6 7 8 9 10
(I)NI
(D)NI
(c)NI
P a g e | 109
If revenue of the companies are kept increasing constantly by 2000 in each year then the
NI of the companies will be go through a linear direction that mean the company will
face mostly constant NI ( with a slight increase) over the 10 year of useful life of PPE
If revenue of the companies are kept deceasing constantly by 2000 in each year then the
NI will be go through a downward direction( but at greater extent) that mean the
company will face greater decrease in NI over the 10 year of useful life of PPE
The ultimate finding is that “ Straight line depreciation method gives a consistent NI
over the years in case of constant and increasing revenue and a good decrease in NI in
case of decreasing Revenue scenario
Diminishing Balance Depreciation Scenario
The diminishing balance method on the other hand assumes that in the early life of the asset, a
higher depreciation charged is more appropriate than in the later life as most assets turn to be
more productive and heavily used when new than when it is old. This involves the application of
a constant rate of depreciation to the diminishing value of the asset. Assume the example above
holds true, with a depreciation rate of 20%, the same asset could be depreciated as follows;
Diminishing Balance Depreciation Charges
YearAnnual Depreciation
ChargeAnnual Depreciation
Percentage Net Book ValueAccumulatedDepreciation
1 2000 20% 8000 20002 1600 20% 6400 36003 1280 20% 5120 48804 1024 20% 4096 59045 819 20% 3277 67236 655 20% 2621 7379
P a g e | 110
7 524 20% 2097 79038 419 20% 1678 83229 336 20% 1342 8658
10 268 20% 1074 8926Source: Own Calculations
It is clear that the depreciation charge for the first three years using the straight line method is
3000 taka (1000+1000+1000) less than that of the diminishing balance method of 4880 taka
(2000+1600+1280) for the same period. A visual comparison of the two common approaches to
depreciation accounting should help in understanding its impact on financial statements.
Figure: Gorge & Hidd ;2005; Depiciation practice & Methods; p.32
P a g e | 110
7 524 20% 2097 79038 419 20% 1678 83229 336 20% 1342 8658
10 268 20% 1074 8926Source: Own Calculations
It is clear that the depreciation charge for the first three years using the straight line method is
3000 taka (1000+1000+1000) less than that of the diminishing balance method of 4880 taka
(2000+1600+1280) for the same period. A visual comparison of the two common approaches to
depreciation accounting should help in understanding its impact on financial statements.
Figure: Gorge & Hidd ;2005; Depiciation practice & Methods; p.32
P a g e | 110
7 524 20% 2097 79038 419 20% 1678 83229 336 20% 1342 8658
10 268 20% 1074 8926Source: Own Calculations
It is clear that the depreciation charge for the first three years using the straight line method is
3000 taka (1000+1000+1000) less than that of the diminishing balance method of 4880 taka
(2000+1600+1280) for the same period. A visual comparison of the two common approaches to
depreciation accounting should help in understanding its impact on financial statements.
Figure: Gorge & Hidd ;2005; Depiciation practice & Methods; p.32
P a g e | 111
Revenueassumed
decreasingby 2000
constantly
Revenueassumedincreasing
by2000
constantly
Revenueassumedconstant
Net BV orending PPE
PPEturnoverfor constant
PPEturnoverforincreasingrevenue
PPEturnoverfordeceasingrevenue
98000 102000 100000 8000 12.5 12.75 12.2596000 104000 100000 6400 15.625 16.25 1594000 106000 100000 5120 19.53125 20.703125 18.35937592000 108000 100000 4096 24.414063 26.367188 22.46093890000 110000 100000 3277 30.515716 33.567287 27.46414488000 112000 100000 2621 38.153377 42.731782 33.57497186000 114000 100000 2097 47.687172 54.363376 41.01096884000 116000 100000 1678 59.594756 69.129917 50.05959582000 118000 100000 1342 74.515648 87.928465 61.10283280000 120000 100000 1074 93.10987 111.73184 74.487896
Table: DB method impact in PPE turnover
Revenueassumed
decreasingby 2000
constantly
Revenueassumed
increasing by2000
constantly
Revenueassumedconstant
DepreciationinDB method
(C)EarningBefore Taxfor constant
(I)EBT forincreasing
Revenue
(D)EBT fordecreasing
Revenue
98000 102000 100000 2000 98000 100000 9600096000 104000 100000 1600 98400 102400 9440094000 106000 100000 1280 98720 104720 9272092000 108000 100000 1024 98976 106976 9097690000 110000 100000 819 99181 109181 8918188000 112000 100000 655 99345 111345 8734586000 114000 100000 524 99476 113476 8547684000 116000 100000 419 99581 115581 8358182000 118000 100000 336 99664 117664 8166480000 120000 100000 268 99732 119732 79732
Table: DB method impact in EBT
P a g e | 112
(C)tax 20%
(D)Tax@20% (I) tax@20%
(c)NI
(D)NI
(I)NI
19600 19200 20000 78400 76800 8000019680 18880 20480 78720 75520 8192019744 18544 20944 78976 74176 83776
19795.2 18195.2 21395.2 79180.8 72780.8 85580.819836.2 17836.2 21836.2 79344.8 71344.8 87344.8
19869 17469 22269 79476 69876 8907619895.2 17095.2 22695.2 79580.8 68380.8 90780.819916.2 16716.2 23116.2 79664.8 66864.8 92464.819932.8 16332.8 23532.8 79731.2 65331.2 94131.219946.4 15946.4 23946.4 79785.6 63785.6 95785.6
Table: DB methods impact in Net income
PPE turnover scenario in diminishing balance depreciation method:
Change in PPE turnover in different simulated condition and in different fiscal year in the
straight-line depreciation will graphically looked like as follow –
0
50
100
150
200
250
300
1 2 3 4 5 6 7 8 9 10
PPEturnover for deceasing revenue
PPEturnover for increasing revenue
PPEturnover for constant
P a g e | 113
Illustration:
if the depreciation is determined in accordance with DB depreciation method then the
companies will face a gradual increase in PPE turnover over 10 year of useful life of PPE
.In last year of useful life of PPE; the PPE will became 0 because there are no residual
value of PPE left.
Ultimate finding is that “company can gain growing PPE return although its revenue is in
increasing, decreasing and constant situation”. In SL depreciation method PPE turnover
will became 0 at the end of 10th year. So in this aspect DB depreciation has good score in
comparative to SL depreciation because it increase profit by the invested amount in PPE
till the end of useful life of PPE.
EBT Scenario in diminishing balance depreciation method:
0
20000
40000
60000
80000
100000
120000
140000
1 2 3 4 5 6 7 8 9 10
(C)Earningbefore tax for constant
(I)EBT forincreasing Revenue
(D)EBT fordecreasing Revenue
P a g e | 114
Illustration:
If revenue of the companies are kept constant then the EBT will be go through a leaner
direction that mean the company will face consistent profit over the 10 year of useful life
of PPE
If revenue of the companies are kept increasing constantly by 2000 in each year then the
EBT will be go through a upward direction that mean the company will face extensive
increase in profit over the 10 year of useful life of PPE
If revenue of the companies are kept deceasing constantly by 2000 in each year then the
EBT will be go through a downward direction that mean the company will face a sharp
decrease in profit over the 10 year of useful life of PPE
The ultimate finding is that “ DB depreciation method gives a inconsistent profit over the
year and thus reducing transparency in profit as well as in case of calculating tax return
Tax scenario in diminishing balance depreciation method:
0
10000
20000
30000
40000
50000
60000
70000
1 2 3 4 5 6 7 8 9 10
(I) tax@20%
(D) tax@20%
(C)tax 20%
P a g e | 115
Illustration:
If revenue of the companies are kept constant then the tax will be go through a leaner
direction( but not so smooth as SL depreciation) that mean the company will face
consistent( may have 5-10% inconsistency) tax return over the 10 year of useful life of
PPE
If revenue of the companies are kept increasing constantly by 2000 in each year then the
tax provision of the companies will be go through a upward direction for 1-4 year then
became consistent in rest of the year that mean the company will face inconstant tax
return over the 10 year of useful life of PPE
If revenue of the companies are kept deceasing constantly by 2000 in each year then the
Tax Return will be go through a downward direction( but at greater extent) that mean
the company will face greater decrease in tax return over the 10 year of useful life of
PPE
The ultimate finding is that “ DB depreciation method gives a consistent (with 5-10%
inconsistency) tax provision over the year in case of constant and increasing revenue
and a good cut of tax return in case of decreasing revenue thus ensuring good
profitability of the companies as well as help in case downturn years ( but not so much as
straight line depreciation )
P a g e | 116
Net Income scenario in Straight Line depreciation system:
Illustration:
If revenue of the companies are kept constant then the NI will be go through a leaner
direction that mean the company will face consistent NI over the 10 year of useful life of
PPE
If revenue of the companies are kept increasing constantly by 2000 in each year then the
NI of the companies will be go through a linear direction that mean the company will
face mostly constant NI ( with a slight increase) over the 10 year of useful life of PPE
If revenue of the companies are kept deceasing constantly by 2000 in each year then the
NI will be go through a downward direction( but at lesser extent in comparative to SL
depreciation) that mean the company will face sharp decrease in comparative to SL
depreciation method in NI over the 10 year of useful life of PPE
0
50000
100000
150000
200000
250000
300000
1 2 3 4 5 6 7 8 9 10
(I)NI
(D)NI
(c)NI
P a g e | 117
The ultimate finding is that “Diminishing balance depreciation method gives a consistent
NI over the years in case of constant and increasing revenue and a sharp decrease in NI
in case of decreasing Revenue scenario
6.6.3. Decision making about validity of developed hypothesis based onanalysis findings:
FINDINGS OF ANALYSIS
FINDINGS OF ANALYSIS
C1
C2
C3
C4
C5
C6
C8
C7
C9
STRAIGHTLINE
DEPRICIATION
Easy to calculate tax ( moretransparent view of profit if taxis kept in a consistent level )
More constraint profit ( NI)over years
Easy to calculate andunderstandable
Good PPE turnover up to ayear before the end of usefullife
Encourage comparability ofprofit across year.
DEMINSIINGBALANCE
DEPRICIATION
Selectedcom
paniescoded
asC
1,C2…
….C
9 PPE turnover up to the end of
PPE useful life May generate SV ( salvage value
)which add some profit intoprofit of the year in which the SVis sold at market price
Inconsistency in tax return (although looked like consistent(5-10% inconsistency ) in case ofincreasing or decreasing revenuesituation)
Inconsistency in profit insuccessive year during life spanof PPE
Comparability of profit acrossyears is somehow compromisedby 5-10%
P a g e | 118
Decision about the validity of H2:
A review of the financial statements for a cross – section of pharmaceutical firms suggests that
PPE is concentrated around the manufacturing industry. Evidence also point to the fact that for
most companies, the Straight-line method of depreciation is a better approach as opposed to the
diminishing balance method.
6.6.4.Depreciation Policy of Selected Listed Companies in Pharmaceutical Industry ofBangladesh
Company Name Depreciation PolicyC1 Straight-Line
C2 Straight-Line
C3 Straight-Line
C4 Straight-Line
C5 Straight-Line
C6 Straight-Line
C7 Straight-Line
C8 Deminishing Balance
C9 Deminishing Balance
SOURCE : Notes to Financial Statements
Based on finding of the Simulated Analysis we can say that adoption of IAS 16 through using
different depreciation method somehow affect PPE Turnover, NI and Tax Return of the
companies.
P a g e | 119
In practice, the depreciation method chosen could have material impact on the financial
statements particularly when comparing company profitability metrics. The reason for this may
be apparent, but for the sake of clarity, let me provide some insights--
For companies using the straight-line method, depreciation expenses are more predictable
and there is a stable deprecation charge over time. The earnings of companies using the
straight line method will be higher in the initial years than companies using the declining
balance approach.
However, for the diminishing balance method, depreciation charge is higher in the initial
years for the asset. This means that depreciation charge for comparable companies will be
different for a given financial period.
6.6.5.Materiality of and Property Plant and Equipment and Its Depreciation (FY 2013)
( All the monetary amount here are expressed in millions)
Companies EBIT (a) EBITDA(b)
Depreciation
and
Amortization
(a-b) PPE
Total
Assets
Deprecation
As
Percentage
of PPE
PPE as
Percentage
of Total
Assets
C1 37019 39973 2954 25418 685913 12% 4%
C2 104891 150684 45793 256853 3415510 18% 8%
C3 162706 164732 2026 19414 1667882 10% 1%
C4 403 3765 3362 45130 74129 7% 61%
C5 21986 38611 16625 143643 197081 12% 73%
C6 570 764 194 1555 3792 12% 41%
C7 52589 55352 2763 20907 516632 13% 4%
C8 25969 30841 4872 29530 68391 16% 43%
C9 86 270 184 6923 9084 3% 76%
Source: annual reports of the respective companies
P a g e | 120
The depreciation rate of assets for some firms differ materially from others as different
depreciation methods are applied with different depreciation rates. However, I should mention
that, as per IAS 16 accounting for Property Plant and Equipment, once a particular depreciation
method is chosen, it should be applied consistently year –on-year. Merely comparing one year
earnings results of two or more companies without taking into account depreciation charge could
obscure visibility on the drivers of earnings. Users of financial statements should be aware that, a
choice of accounting policy for PPE, i.e. the cost model or the revaluation method to a large
extent determines the depreciation charge on an annual basis.
P a g e | 121
6.7. Proving Hypothesis 3: IAS Compliance in Consistent Manner andComparability of Financial Statements Among Selected Companies has aPositive Relation
6.7.1. Brief Identification
Comparability means complying or staying with a single IAS rule (whereby multiple IAS hasavailable to perform similar treatments) overtime (Henry, Josef 1998). In simple waycomparability means doesn’t changing accounting police over the years until IFRS allow it.Comparability is mainly two types-comparability of financial statement of the same companyover the years and comparability of financial statement among industry firms.
Scoring variable:
Change in accounting policy, estimates and error (independent variable) scoring procedure------
Yes
Compare
No
Since comparability is justified based on over the year consistency of accounting policies; we
should select 9 year annual report data on IAS compliance accounting practice , policies and
prescribed methods (including data of 2013) and justify their consistency / comparability across
years.
All the scores given in the table are accumulated and average score of consistency/
compatibilities of 9 companies (C1, C2, C3, C4, C5, C6, C7, C8 and C9) -----
Accountingpolicy adoptedby a singlecompany(among 9companies)for the firsttime
Accountingpoliciesapplied innext years
Iscompared
?
Yes= (1/9)
No= (0/9)
P a g e | 122
Related IAS
Particulars 2005
2006
2007
2008
2009
2010
2011
2012
2013
2014IAS-1 Followinggoingconcernprincipleover theyear by the9 companies
1 1 1 1 1 1 1 1 1 1
IAS-16 PP&Evaluation atcost anddeprecatedover itsuseful life1 1 1 1 1 1 1 1 1 1
IAS-16 Depreciatethe asset atetherstraight lineanddiminishingbalancedepreciationmethod
1 1 1 1 1 1 1 1 0.78 0.78
IAS -2 Calculatingrawmaterial ,packing andwork inprogress1 1 1 1 1 1 1 1 1 1
IAS-2 Finishedgoodsaccounting 1 1 1 1 1 1 1 1 1 1IAS-2 Spare partsandaccessoriesaccounting
1 1 1 1 1 1 1 1 1 1IAS-2 Good intransitaccounting 1 1 1 1 1 1 1 1 1 1IAS -12 Income taxis calculatedas per as taxrules
1 1 1 1 1 1 0.89 1 1 0.89IAS -18 Revenuerecognitionin case ofsales of
1 1 1 1 1 1 1 1 1 1
P a g e | 123
goodsIAS-18 Dividendrecognitionaccounting 1 1 1 1 1 1 1 1 1 1
IAS-18 Interestincomerecognitionaccountingpractice1 1 1 1 1 1 1 1 1 1
IAS-21 Foreigncurrencytrisectionexchangerate anddealing withyearendtransactionsdenominated in foreigncurrency
1 1 1 1 1 1 1 1 1 1
IAS-7 CFstatementpreparation 1 1 1 1 1 1 .89 1 .78 1IAS-33 EPScalculation 1 1 1 1 1 1 1 1 1 1Explanation of the table in a sequential order (top to bottom):
IAS-1: all the 9 companies follow going concern principle consistently over the 9 years
in case of preparing, recoding, dealing accounting trisections and their respective
financial statements. So we score them as all with 1.
IAS-16 : all the 9 company record PP&E at their historical cost and depreciate it over
their useful life
IAS-16: All the company consistently follow straight line depreciation method
consistently up to 2010 and in year 2013 C8 and c9 switch from straight line depreciation
into diminishing balance method . In 2014 C8 and C9 returned back into straight line
depreciation method due to some systematic and reporting difficulties
P a g e | 124
IAS-2: calculate the raw material, packing materials and work in progress in term of
weighted cost over the years consistently by all the 9 companies. So we assign 1 to each
year.
IAS-2: calculate the finished goods at lower of cost or net estimated realizable value
consistently over the years by all the 9 companies. So we assign 1 to each year
IAS-2: calculate the Spare & Accessories in term of weighted cost over the years
consistently by all the 9 companies. So we assign 1 to each year.
IAS-2: Good-in transit is calculated at cost over the years consistently by all the 9
companies. So we assign 1 to each year
IAS-12: in the year 2011 and 2013 government creates some amendments in income tax
rule and regulation for the industry; that’s why a little bump in consistency has reveal in
this 2 year. We also observe a good consistency in between years (2005-2010); so we
score them up with 1.
IAS-18: revenue from sale of goods is consistently maintained as follow consistently
across the years so we score them with 1 –
Revenue is recognized for local sales of Pharmaceuticals Drugs and Medicines, Agro Vet
Products and Pesticide Products at the time of delivery from depot and Exports of
Pharmaceuticals Drugs and Medicines at the time of delivery from Factory Go down
IAS-18: Dividend income is recognized by the companies across the years when the right
to received payment is established. So we score the consistency and comparability with 1
IAS-18: interest income is recognized by the companies across the years when accrued
on a time proportion basis. So we score the consistency and comparability with 1
IAS-21: foreign exchange transaction denominated in another currency is translated into
taka from foreign currency at the each year end by using the current rate rather than using
spot rate or average rate. This practice is consistently followed by companies over 9 year
; so we score them with 1
IAS-7: cash flow statement is prepared by the companies in direct approach up to 2010
and later “in 2011 C8” and “in 2013 C7 and C9” adopt indirect approach to record cash
flow transactions. So inconsistency arises in 2011 and 2013 which hamper comparability
with previous year FSs as well as across industry firms.
P a g e | 125
IAS-33: EPS is calculated as per as IAS-33 guided way over the 9 year with a persistent
manner. So we assign 1 to all years
On an average comparability across in the respective IAS in overall years is demonstrated in
graph-
IAS title Comparability score( on average over years)
IAS-1 1IAS-16 1IAS-16 0.946282967IAS-2 1IAS-2 1IAS-2 1IAS-2 1IAS-12 0.974436032IAS-18 1IAS-18 1IAS-18 1IAS-21 1IAS-7 0.96025633
IAS-33 1Source: self-calculation
Graphical look:
0.910.920.930.940.950.960.970.980.99
11.01
Comparibilty score
Comparibilty score
P a g e | 126
Now we want to look over comparability across years in respect of overall IAS (underconsideration) among the 9 companies---
Graphical outlook:
0.95
0.96
0.97
0.98
0.99
1
1.01
2005 2006 2007 2008 2009 2011 2012 2013 2014
Comparbilityaross years
Comparbilityaross years
Year Comparabilityacross years
2005 12006 12007 12008 12009 12011 0.982012 12013 0.972014 0.97
P a g e | 127
Findings:
Excellent comparability: Since comparability across companies with IAS compliance isranged in between 94-100%
Excellent Comparability across years: Since comparability across years with overall IAScompliance is ranged from 97-100%
The more consistency in first adopted IAS the more the comparability will be amongfirms in case of comparing financial statements , annual report , and audit reports
6.7.2. Decision Making: About Hypothesis 3
H1: IAS compliance in consistent manner and comparability of financial statements amongselected companies has a positive relation. (Supported by the limited and short analysis
and has been verified as true)
H0: IAS compliance in consistent manner and comparability of financial statements amongselected companies has a negative relation (proved wrong)
P a g e | 128
Chapter 7FINDINGS, RECOMMENDATIONS AND CONCLUSIONSTHIS CHAPTER WILL COVERS THE FOLLOWING THINGS:
1. Report down the major findings of the detailed analysis2. Forecast the consequence of those finding3. Positive and negative aspect detected in finding4. Best performing companies based on findings5. Recommendation for lower positioned firms in the light of findings
P a g e | 128
Chapter 7FINDINGS, RECOMMENDATIONS AND CONCLUSIONSTHIS CHAPTER WILL COVERS THE FOLLOWING THINGS:
1. Report down the major findings of the detailed analysis2. Forecast the consequence of those finding3. Positive and negative aspect detected in finding4. Best performing companies based on findings5. Recommendation for lower positioned firms in the light of findings
P a g e | 128
Chapter 7FINDINGS, RECOMMENDATIONS AND CONCLUSIONSTHIS CHAPTER WILL COVERS THE FOLLOWING THINGS:
1. Report down the major findings of the detailed analysis2. Forecast the consequence of those finding3. Positive and negative aspect detected in finding4. Best performing companies based on findings5. Recommendation for lower positioned firms in the light of findings
P a g e | 129
7.0. Major Findings
IAS -1 compliance:
In preparation Consolidated Financial Statement companies in sample
ensure 85-95% compliance
In preparation Cash Flow Statement companies in sample ensure 77.5-
92.5% compliance
In preparation Comprehensive Income Statement companies in sample
ensure 80-90% compliance
In preparation Statement of Change in Equity companies in sample
ensure 99-100% compliance
In maintaining general provisions of IAS-1 companies in sample
ensure 62.5-72.5% compliance
Dispersion of compliance score in different part of IAS-1 compliance
less.
Cash flow item compliance with IAS-1 in total compliance
of all sample companies is 22%
Statement of change inequity compliance with IAS-1 in
total compliance of all sample companies is 22%
General compliance with IAS-1 in total compliance of all
sample companies is 16%
Consolidated financial statement item compliance with IAS-
1 in total compliance of all sample companies is 20%
Comprehensive income item compliance with IAS-1 in total
compliance of all sample companies is 20%
IAS-16 adoption through using different depreciation method has influence on
profit , PP&E turnover and tax return:
P a g e | 130
Finding in simulated analysis conducted for straight line depreciation
method are as follow-
Easy to calculate tax ( more transparent view of profit
if tax is kept in a consistent level )
More constraint profit ( NI) over years
Easy to calculate and understandable
Good PPE turnover up to a year before the end of
useful life
Encourage comparability of profit across year
Finding in simulated analysis conducted for diminishing balance
depreciation method are as follow-
PPE turnover up to the end of PPE useful life
May generate SV ( salvage value )which add some profit
into profit of the year in which the SV is sold at market
price
Inconsistency in tax return ( although looked like
consistent( 5-10% inconsistency ) in case of increasing or
decreasing revenue situation)
Inconsistency in profit in successive year during life span of
PPE
Comparability of profit across years is somehow
compromised by 5-10%
Majority of firm in the industry follow straight line depreciation
method due to it is consistent in nature and straight forward.
IAS compliance in consistent manner and comparability of financial statements
among selected companies has a positive relation.
Major findings of this analytical part is given in epitomized form bellow-
Excellent comparability across IASs: Since comparability across
companies with IAS compliance is ranged in between 94-100%
P a g e | 131
Excellent Comparability across years: Since comparability across years
with overall IAS compliance is ranged from 97-100%
The more consistency in first adopted IAS the more the comparability will
be among firms in case of comparing financial statements , annual report ,
and audit reports
7.1. Forecast the Consequence of those Findings
Companies are increasingly complying with IAS ; so we can predict in future
companies will became totally accustomed with IAS compliance
If companies consistently follow the first adopted uniformly the comparability
among industry firm will increase in future which will reduce confusion and
suspension for investor , shareholders and other concerned authorities ; who
usually analyze accounting information of the companies. In future we can predict
a good internal and external comparability among industries
7.2. Positive and Negative Aspect Detected in Finding
Positive aspects: Companies follow IAS in preparation of financial statement and ensure
major requirement of IAS-1. So financial statement demonstration is done in an
transparent way with 89% IAS-1 compliance
Negative aspect: Some of the firm break consistency of firstly adopted IAS thus tousle
situation arise in comparability. Due to government interference and frequent change in
national accounting policies level of consistency and comparability are also beaked down
frequently.
Companies properly follow most of the guideline FS presentation but somehow fight shy
some general IAS provision due to obsolesce in this industry or elimination done by
ICAB or contingent situation or firm’s negligence.
P a g e | 132
7.3. Best Performing Companies based on Findings
Good Performer in IAS Compliance Related Issues
Company codes in analysis Company name
C1 Square Pharmaceuticals
C2 Incepta Pharmaceuticals
C3 Beximco Pharmaceuticals
C4 IBN SINA Pharmaceutical Industry Ltd.
C5 ACI Ltd
C6 Popular Pharmaceuticals Ltd. (PPL)
C7 Delta Pharma Ltd
7.4. Poor Performing Companies Based on Findings:
Comparatively Poor Performer in IAS Compliance Related Issues
C8 Sun Pharmaceutical (Bangladesh) Ltd
C9 Radiant Pharmaceuticals Ltd
7.5. Recommendation for Lower Positioned Firms in the Light of Findings
C8 and C9 scored less comparatively in general provision compliance of IAS-1 and they
switch from one depreciation method to depreciation (straight line to declining balance
method) in between 2011-2014. So these two firm should –
1. Go back to straight line depreciation; because most of the firms in the
pharmaceutical industry exercise straight line depreciation; to ensure
comparability of their financial statement and reporting.
P a g e | 133
2. Should follow general provision that has been adopted by ICAB and
industry itself.
7.6. Conclusion:
IAS compliance ensures a discipline way to manage accounting matters through reducing
differentiations in treating accounting issues; thus ensure tranquility in whole world’s accounting
system. In Bangladesh a major part of industry is chemicals industry and pharmaceutical industry
is a major share of it. So this industry’s financial reporting should be done in accordance with
Bangladesh financial reporting standards which are national customized form of IFRS.
Throughout the study we realize that this industry is maintain a good compliances of IAS in
general and it is also expected that in near future due to globalization and necessity of single
accounting practice all the industry firm will compelled to follow IAS /BAS in every accounting
aspects.
P a g e | 134
BIBLIOGRAPHY
THIS PART INCLUDES:
Demonstrating workings through PC screen shoot and cheek list (that are notpresented in analysis part due to limitation of space.)
Proving reference of all source of data used while conducting the study throughHarvard Referencing System
Extension of Abbreviations that are used in whole study
P a g e | 134
BIBLIOGRAPHY
THIS PART INCLUDES:
Demonstrating workings through PC screen shoot and cheek list (that are notpresented in analysis part due to limitation of space.)
Proving reference of all source of data used while conducting the study throughHarvard Referencing System
Extension of Abbreviations that are used in whole study
P a g e | 134
BIBLIOGRAPHY
THIS PART INCLUDES:
Demonstrating workings through PC screen shoot and cheek list (that are notpresented in analysis part due to limitation of space.)
Proving reference of all source of data used while conducting the study throughHarvard Referencing System
Extension of Abbreviations that are used in whole study
P a g e | 135
Part 1- References
Ahmed, K. (1996). Disclosure policy choice and corporate characteristics: A study of
Bangladesh. Asian-PacificJournal of Accounting, 3(1), 183 −203.
Ahmed M .U, Bala,S.K and Chowdury,A (2006), Financial Reporting in Compliance
with International Accounting Standards. A study in Bangladesh with reference IAS 1,
Journal of Business Studies, Volume XXV, No.2, December (2004).
Abdelrahim, A. M., & Mostafa, G. N. (2000). Accounting for investment for listed
companies on the KSE. AlMuhasiboon (The Accountants), 6(16), 30 −45.
Abdelrahim, A. M., Hewaidy, A. M., & Mostafa, G. N. (1997). The relevance of
international accounting standards to the evaluation of fixed assets in Kuwait
corporations. Arab Journal of Administrative Sciences, 5(1), 53 −96.
Ahmed, K., & Nicholls, D. (1994). The impact of non-financial company characteristics
on mandatory disclosure compliance in developing countries: The case of Bangladesh.
International Journal of Accounting, 19(3), 62 −77.
Barth, R., Landsman, W., & Lang, M. (2008). International accounting standards and
accounting quality. Journal of Accounting Research, 46(3), 467 −498.
Ball, R., & Foster, G. (1982). Corporate financial reporting: A methodological review of
empirical research. Journal of Accounting Research, 20(Supplement), 161 −234.
Zahir M. (2000), Company and Securities Laws (Dhaka, The University Press Ltd.).
P a g e | 136
Kieso, Donald E., Weygandt, Jerry J & Warfield, Terry D. Intermediate Accounting (11
th Edition).
Weygandt, Jerry J., Kieso, Donald E. & Kimmel,Paul D. Accounting Principles (9th
Edition).
Al-Shammari, B., Brown, P., & Tarca, A. (2007). Development of enforcement
mechanisms following adoption of International Accounting Standards in the Gulf
Cooperation Council Member States, Working paper, University of Western Australia.
Available at http://ssrn.com/author=106179
Hanushek, E. A., & Jackson, J. E. (1977). Statistical methods for social scientists. New
York: Academic Press
Hussain, M., Islam, M. M., Gunasekaran, A., & Maskooki, K. (2002). Accounting
standards and practices of financial institutions in GCC member countries. Managerial
Auditing Journal, 17(7), 350.
International Accounting Standards Committee (IASC) (1996). International Accounting
Standards and SIC interpretations. London: IASC.
Joshi, L., & Al-Mudhahki, J. (2001). Empirical study of compliance with international
accounting standards (IAS 1) by stock exchange listed companies. Journal of Financial
Management and Analysis, 14(2), 43 −54.
Murphy, A. (2000). The impact of adopting international accounting standards on the
harmonization of accounting practices. International Journal of Accounting, 35(4), 471
−493
P a g e | 137
Street, D. L., Gray, S. J., & Bryant, S. M. (1999). Acceptance and observance of
international accounting standards: An empirical study of companies claiming to comply
with IASs. International Journal of Accounting, 34(1), 11 −48
Tower, G., Hancock, P., & Taplan, R. (1999). A regional study of listed companies'
compliance with international accounting standards. Accounting Forum, 23(3), 293 −305.
Watts, R., & Zimmerman, J. (1986). Positive accounting theory. New Jersey: Prentice-
Hall Inc
Watts, R., & Zimmerman, J. (1978). Towards a positive theory of the determination of
accounting standards. Accounting Review, 53(1), 112 −134
P a g e | 138
Part 2-Workings
PC calculation snapshots
P a g e | 138
Part 2-Workings
PC calculation snapshots
P a g e | 138
Part 2-Workings
PC calculation snapshots
P a g e | 139
P a g e | 140
Other ruffs/ scratch calculation that are made and used indirectly in analysis part
IAS compliance in case of presenting financial statement in the year 2013
Name of itemsrelevantIAS C1 C2 C3 C4 C5 C6 C7 C8 C9 Mean
Balance sheetitem
PP&E IAS 16 1 1 1 1 1 1 1 1 1 1
Investment inshare IAS 28 1 1 1 1 1 1 1 1 1 1Intangibleasset IAS 38 1 1 1 1 1 1 1 1 1 1
Inventories IAS 2 1 1 1 1 1 1 1 1 1 1Spares &Supplies IAS 2 1 1 1 1 1 1 1 1 1 1AccountsReceivable IAS 39 1 1 1 1 1 1 1 1 1 1Loans,
Advances andDeposits IAS 39 1 1 1 1 0.5 0.5 1 0.5 0.5 0.7778Short TermInvestment IAS 7 1 1 0 0.5 0.5 0 1 1 1 0.6667Cash and CashEquivalents IAS 7 1 1 1 1 0.5 1 1 1 1 0.9444
Issued ShareCapital IAS 32 1 1 1 1 1 1 1 1 0 0.8889
SharePremium IFRS 2 1 1 1 1 1 1 1 1 1 1
CapitalReserve onMerger IAS 1 1 0 0 0 0 0 1 0 1 0.3333RevaluationSurplus IAS 16 1 1 1 1 1 1 1 1 1 1Fair ValueGain onInvestment IAS 40 1 0.5 1 1 1 0.5 0.5 1 1 0.8333Retained
Earnings IAS 1 1 1 1 1 1 1 1 1 1 1Total
compliancescore of 9companies 13.444
P a g e | 141
Number of item inbalance sheet part
100%compliance
score
Companiestotal
compliancescore
% ofcompliance Comment
18 item 18 13.44444444 74.69135802Goodcompliance
IAS compliance in case of presenting Financial statements( income statements )in the year end December 31 2013
Name of itemsrelevantIAS C1 C2 C3 C4 C5 C6 C7 C8 C9 Mean
Cost of goods sold IAS 2
Administrative Expenses IAS 19
Selling, Marketing andDistribution Expenses IAS 1
Other Income IAS 1
Finance Cost IAS 23
Contribution to WPPF & Welfare Funds IAS 1
Current Tax IAS 12
Deferred Tax IAS 12
Other Comprehensive Income IAS 1
Fair Value Gain on Investment in ListedShares IAS 40
P a g e | 142
Part 3-Extensions of Abbreviations
FS=financial statement
CF= cash flow
ICAB= Institute of Certified
Accounting of Bangladesh
BFRS= Bangladesh Financial
Reporting Standards
BAS= Bangladesh Accounting
Standards
GAAP= Generally Accepted
Accounting Principles
C1: Square Pharmaceuticals
C3= Beximco Pharmaceuticals
C4= IBN SINA Pharmaceutical
Industry Ltd.
C5= ACI Ltd
C6= Popular Pharmaceuticals Ltd.
(PPL)
C2= Incepta Pharmaceuticals
C7= Delta Pharma Ltd
C8= Sun Pharmaceutical
(Bangladesh) Ltd
C9= Radiant Pharmaceuticals Ltd